taxonomy (10)
protein (198)
source (22)
structure (38)
composition (1)
disease (13)
reference (45)
site (312)
peptide (311)
- Homo sapiens (Human)
- Bos taurus (Bovine)
- Canis lupus familiaris (Dog)
- Equus caballus (Domestic horse)
- Mus musculus (House mouse)
- Ovis aries (Sheep)
- Gallus gallus (Chicken)
- Torpedo californica (Pacific electric ray)
- Friend murine leukemia virus (F-mulv)
- Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
Taxonomy
- ADAM DEC1 / Homo sapiens O15204
- ADAMTS-like protein 2 / Homo sapiens Q86TH1
- Adenosine deaminase 2 / Homo sapiens Q9NZK5
- Adhesion G protein-coupled receptor F5 / Homo sapiens Q8IZF2
- Adhesion G protein-coupled receptor L4 / Homo sapiens Q9HBW9
- Adhesion G-protein coupled receptor D1 / Homo sapiens Q6QNK2
- Alpha-1-acid glycoprotein 1 / Homo sapiens P02763
- Alpha-1-acid glycoprotein 2 / Homo sapiens P19652
- Alpha-1-antichymotrypsin / Homo sapiens P01011
- Alpha-1-antitrypsin / Homo sapiens P01009
- Alpha-1b-glycoprotein / Homo sapiens P04217
- Alpha-2-HS-glycoprotein / Homo sapiens P02765
- Alpha-2-macroglobulin / Homo sapiens P01023
- Alpha-n-acetylglucosaminidase / Homo sapiens P54802
- Angiopoietin-1 receptor / Homo sapiens Q02763
- Angiopoietin-related protein 4 / Homo sapiens Q9BY76
- Angiotensin-converting enzyme / Homo sapiens P12821
- Angiotensin-converting enzyme 2 / Homo sapiens Q9BYF1
- Angiotensinogen / Homo sapiens P01019
- Apolipoprotein (a) / Homo sapiens P08519
- Apolipoprotein B-100 / Homo sapiens P04114
- Apolipoprotein D / Homo sapiens P05090
- Apolipoprotein F / Homo sapiens Q13790
- Asialoglycoprotein receptor 2 / Homo sapiens P07307
- Attractin / Homo sapiens O75882
- Basement membrane-specific heparan sulfate proteoglycan core protein / Homo sapiens P98160
- Beta-2-glycoprotein 1 / Homo sapiens P02749
- Beta-Ala-His dipeptidase / Homo sapiens Q96KN2
- Biotinidase / Homo sapiens P43251
- Bone marrow stromal antigen 2 / Homo sapiens Q10589
- C4b-binding protein alpha chain / Homo sapiens P04003
- C4b-binding protein beta chain / Homo sapiens P20851
- Cadherin-13 / Homo sapiens P55290
- Carboxypeptidase b2 / Homo sapiens Q96IY4
- Carboxypeptidase N subunit 2 / Homo sapiens P22792
- Carcinoembryonic antigen-related cell adhesion molecule 5 / Homo sapiens P06731
- Catalase / Homo sapiens P04040
- Cathepsin D / Homo sapiens P07339
- Cathepsin L1 / Homo sapiens P07711
- CD109 antigen / Homo sapiens Q6YHK3
- CD166 antigen / Homo sapiens Q13740
- CD276 antigen / Homo sapiens Q5ZPR3
- CD44 antigen / Homo sapiens P16070
- CD48 antigen / Homo sapiens P09326
- Ceruloplasmin / Homo sapiens P00450
- Cholesteryl ester transfer protein / Homo sapiens P11597
- Clusterin / Homo sapiens P10909
- Coagulation factor IX / Homo sapiens P00740
- Coagulation factor VIII / Homo sapiens P00451
- Coagulation factor XI / Homo sapiens P03951
- Coagulation factor XIII B chain / Homo sapiens P05160
- Collagen alpha-3(VI) chain / Homo sapiens P12111
- Complement factor h / Homo sapiens P08603
- Complement factor H-related protein 1 / Homo sapiens Q03591
- Complement factor H-related protein 3 / Homo sapiens Q02985
- Complement factor H-related protein 4 / Homo sapiens Q92496
- Complement factor i / Homo sapiens P05156
- Contactin-3 / Homo sapiens Q9P232
- Contactin-4 / Homo sapiens Q8IWV2
- Corticosteroid-binding globulin / Homo sapiens P08185
- Decorin / Homo sapiens P07585
- Desmoglein-2 / Homo sapiens Q14126
- Ecto-ADP-ribosyltransferase 4 / Homo sapiens Q93070
- Endoplasmic reticulum aminopeptidase 2 / Homo sapiens Q6P179
- Endothelial cell-selective adhesion molecule / Homo sapiens Q96AP7
- Endothelin-converting enzyme 1 / Homo sapiens P42892
- Epidermal growth factor receptor / Homo sapiens P00533
- Epididymis-specific alpha-mannosidase / Homo sapiens Q9Y2E5
- Erythropoietin / Homo sapiens P01588
- Extracellular matrix protein 1 / Homo sapiens Q16610
- Extracellular sulfatase Sulf-2 / Homo sapiens Q8IWU5
- Fibrillin-1 / Homo sapiens P35555
- Fibroleukin / Homo sapiens Q14314
- Follitropin, alpha and beta chains / Homo sapiens P01225 P01215
- Frizzled-6 / Homo sapiens O60353
- G-protein coupled receptor 126 / Homo sapiens Q86SQ4
- Galectin-3-binding protein / Homo sapiens Q08380
- Gamma-glutamyltranspeptidase 1 / Homo sapiens P19440
- Glutaminase kidney isoform, mitochondrial / Homo sapiens O94925
- Glycocalicin / Homo sapiens P07359
- Haptoglobin / Homo sapiens P00738
- Hemopexin / Homo sapiens P02790
- Heparin cofactor 2 / Homo sapiens P05546
- Hepatocyte growth factor / Homo sapiens P14210
- Hepatocyte growth factor activator / Homo sapiens Q04756
- Hepatocyte growth factor receptor / Homo sapiens P08581
- HLA class II histocompatibility antigen, DP alpha 1 chain / Homo sapiens P20036
- Homeobox protein Hox-B3 / Homo sapiens P14651
- IgGFc-binding protein / Homo sapiens Q9Y6R7
- Immunoglobulin alpha-2 heavy chain (secretory) - heavy chain 1 / Homo sapiens P0DOX2
- Immunoglobulin alpha-2 heavy chain (secretory) - heavy chain 2 / Homo sapiens P0DOX2
- Immunoglobulin alpha-2 heavy chain (secretory) - heavy chain 3 / Homo sapiens P0DOX2
- Immunoglobulin heavy constant alpha 1 / Homo sapiens P01876
- Immunoglobulin heavy constant alpha 1 - heavy chain 1 / Homo sapiens P01876
- Immunoglobulin heavy constant alpha 1 - heavy chain 2 / Homo sapiens P01876
- Immunoglobulin heavy constant alpha 2 / Homo sapiens P01877
- Immunoglobulin heavy constant alpha 2 - heavy chain 1 / Homo sapiens P01877
- Immunoglobulin heavy constant delta / Homo sapiens P01880
- Immunoglobulin heavy constant delta - heavy chain 2 / Homo sapiens P01880
- Immunoglobulin heavy constant epsilon - heavy chain 1 / Homo sapiens P01854
- Immunoglobulin heavy constant epsilon - heavy chain 2 / Homo sapiens P01854
- Immunoglobulin heavy constant gamma 2 / Homo sapiens P01859
- Immunoglobulin heavy constant mu / Homo sapiens P01871
- Integrin alpha-5 / Homo sapiens P08648
- Integrin alpha-5/beta-1 / Homo sapiens P08648 P05556
- Inter-alpha-trypsin inhibitor heavy chain h1 / Homo sapiens P19827
- Inter-alpha-trypsin inhibitor heavy chain h2 / Homo sapiens P19823
- Inter-alpha-trypsin inhibitor heavy chain h4 / Homo sapiens Q14624
- Intercellular adhesion molecule 2 / Homo sapiens P13598
- Interleukin-1 receptor accessory protein / Homo sapiens Q9NPH3
- Interleukin-1 receptor-like 1 / Homo sapiens Q01638
- Interleukin-6 receptor subunit beta / Homo sapiens P40189
- Junction plakoglobin / Homo sapiens P14923
- Kallistatin / Homo sapiens P29622
- Keratin, type I cytoskeletal 9 / Homo sapiens P35527
- Kininogen-1 / Homo sapiens P01042
- Lactotransferrin / Homo sapiens P02788
- Laminin subunit alpha-2 / Homo sapiens P24043
- Laminin subunit alpha-4 / Homo sapiens Q16363
- Laminin subunit gamma-1 / Homo sapiens P11047
- Latent transforming growth factor beta binding protein 1 / Homo sapiens Q14766
- Leptin receptor / Homo sapiens P48357
- Leucine-rich repeat-containing protein 15 / Homo sapiens Q8TF66
- Leucyl-cystinyl aminopeptidase / Homo sapiens Q9UIQ6
- Lipopolysaccharide-binding protein / Homo sapiens P18428
- Lumican / Homo sapiens P51884
- Lysosome-associated membrane glycoprotein 1 / Homo sapiens P11279
- Lysosome-associated membrane glycoprotein 2 / Homo sapiens P13473
- Macrophage colony-stimulating factor 1 receptor / Homo sapiens P07333
- Maltase-glucoamylase, intestinal / Homo sapiens O43451
- Mannan-binding lectin serine protease 1 / Homo sapiens P48740
- Mesothelin / Homo sapiens Q13421
- Mimecan / Homo sapiens P20774
- Multimerin-1 / Homo sapiens Q13201
- Multimerin-2 / Homo sapiens Q9H8L6
- Multiple epidermal growth factor-like domains protein 8 / Homo sapiens Q7Z7M0
- Myeloperoxidase / Homo sapiens P05164
- Neogenin / Homo sapiens Q92859
- Neuron navigator 2 / Homo sapiens Q8IVL1
- Noelin / Homo sapiens Q99784
- Oncoprotein-induced transcript 3 protein / Homo sapiens Q8WWZ8
- Oncostatin-M-specific receptor subunit beta / Homo sapiens Q99650
- Peroxidasin homolog / Homo sapiens Q92626
- Phosphatidylinositol-glycan-specific phospholipase D / Homo sapiens P80108
- Plasma protease c1 inhibitor / Homo sapiens P05155
- Plasma serine protease inhibitor / Homo sapiens P05154
- Plasminogen / Homo sapiens P00747
- Platelet endothelial cell adhesion molecule / Homo sapiens P16284
- Platelet glycoprotein V / Homo sapiens P40197
- Platelet-derived growth factor subunit b / Homo sapiens P01127
- Plexin-B1 / Homo sapiens O43157
- Plexin-B2 / Homo sapiens O15031
- Polymeric immunoglobulin receptor / Homo sapiens P01833
- Prolactin-inducible protein / Homo sapiens P12273
- Prolargin / Homo sapiens P51888
- Prolow-density lipoprotein receptor-related protein 1 / Homo sapiens Q07954
- Prostaglandin-h2 d-isomerase / Homo sapiens P41222
- Protein heg homolog 1 / Homo sapiens Q9ULI3
- Prothrombin / Homo sapiens P00734
- Receptor-type tyrosine-protein phosphatase C / Homo sapiens P08575
- Receptor-type tyrosine-protein phosphatase gamma / Homo sapiens P23470
- Receptor-type tyrosine-protein phosphatase kappa / Homo sapiens Q15262
- Receptor-type tyrosine-protein phosphatase mu / Homo sapiens P28827
- Scavenger receptor cysteine-rich type 1 protein M130 / Homo sapiens Q86VB7
- Secretogranin-3 / Homo sapiens Q8WXD2
- Selenoprotein P / Homo sapiens P49908
- Semaphorin-4D / Homo sapiens Q92854
- Serotransferrin / Homo sapiens P02787
- Serum paraoxonase/arylesterase 1 / Homo sapiens P27169
- Tenascin-N / Homo sapiens Q9UQP3
- Tensin-2 / Homo sapiens Q63HR2
- Thrombospondin-1 / Homo sapiens P07996
- Thyroxine-binding globulin / Homo sapiens P05543
- Trem-like transcript 2 protein / Homo sapiens Q5T2D2
- Tumor necrosis factor receptor superfamily member 21 / Homo sapiens O75509
- Type 2 lactosamine alpha-2,3-sialyltransferase / Homo sapiens Q9Y274
- Tyrosine-protein kinase Mer / Homo sapiens Q12866
- Tyrosine-protein kinase receptor TYRO3 / Homo sapiens Q06418
- Tyrosine-protein kinase receptor UFO / Homo sapiens P30530
- Uncharacterized protein from Blood Serum / Homo sapiens
- Uromodulin / Homo sapiens P07911
- Vascular cell adhesion protein 1 / Homo sapiens P19320
- Vitronectin / Homo sapiens P04004
- Voltage-dependent calcium channel subunit alpha-2/delta-1 / Homo sapiens P54289
- Von willebrand factor / Homo sapiens P04275
- Zinc-alpha-2-glycoprotein / Homo sapiens P25311
- Acetylcholinesterase / Bos taurus P23795
- Alpha-1-acid glycoprotein / Bos taurus Q3SZR3
- Alpha-2-hs-glycoprotein / Bos taurus P12763
- Alpha-1-acid glycoprotein / Canis lupus familiaris F6Y713
- Uncharacterized protein from Dander / Equus caballus
- Synaptophysin-like protein 1 / Mus musculus O09117
- Alpha-1-acid glycoprotein / Ovis aries W5P7S6
- Riboflavin-binding protein / Gallus gallus P02752
- Acetylcholine receptor protein / Torpedo californica P02714 P02718 P02712 P02710
- Envelope glycoprotein / Friend murine leukemia virus P03395
- Recombinant Spike glycoprotein (FreeStyle 293-F) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) P0DTC2
- Recombinant Spike glycoprotein (HEK293) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) P0DTC2
Protein
- Blood Plasma (UBERON_0001969)
- Blood Serum (UBERON_0001977)
- Bone Marrow (UBERON_0002371)
- Brain (UBERON_0000955)
- Colon (UBERON_0001155)
- Dander
- Electric Organ (UBERON_0006869)
- Kidney (UBERON_0002113) HEK293-EBNA (CVCL_6974)
- Liver (UBERON_0002107)
- Mammary Gland (UBERON_0001911)
- Milk (UBERON_0001913)
- Ovary (UBERON_0000992) CHO (CVCL_0213)
- Placenta (UBERON_0001987)
- Umbilical Vein (UBERON_0002066) Endothelial Cell of Umbilical Vein (CL_0002618)
- Urine (UBERON_0001088)
- Eveline (CVCL_A1LI)
- FreeStyle 293-F (CVCL_D603)
- HEK293 (CVCL_0045)
- Jurkat (CVCL_0065)
- LS174T (CVCL_1384)
- Low-Density Lipoprotein Particle (GO_0034362)
- Yolk (GO_0060417)
Source
- N-Linked / Complex / Gal(b1-4)GlcNAc(?1-?)[Gal(b1-4)GlcNAc(?1-?)]Man(a1-?)[Gal(b1-4)GlcNAc(?1-?)Man(a1-?)]Man(b1-4)GlcNAc(b1-4)GlcNAc+"+ 2 x NeuAc(a2-?)"
- N-Linked / Complex / Gal(b1-4)GlcNAc(?1-?)Man(a1-3)[Gal(b1-4)GlcNAc(?1-?)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc+"+ Gal(b1-4)GlcNAc(?1-?) + 2 x NeuAc(a2-?)"
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-4)]Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc+"+ 2 x NeuAc"
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-4)]Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc+"+ 2 x NeuAc(a2-3)"
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-4)]Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc+"+ 2 x NeuAc(a2-?)"
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-6)]Man(a1-6)[Gal(b1-4)GlcNAc(b1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)GlcNAc+"+ 2 x NeuAc(a2-3)"
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-?)]Man(a1-?)[Gal(b1-4)GlcNAc(b1-2)Man(a1-?)]Man(b1-4)GlcNAc(b1-4)GlcNAc+"+ 2 x NeuAc(a2-?)"
- N-Linked / Complex / Gal(b1-?)GlcNAc(b1-?)Man(a1-6)[Gal(b1-?)GlcNAc(b1-?)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)GlcNAc+"+ Gal(b1-?)GlcNAc(b1-?) + NeuAc(a2-3) + NeuAc(a2-6)"
- N-Linked / Complex / NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-4)]Man(a1-3)[NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-6)]Man(a1-6)[NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-2)[NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-4)]Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-2)[NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-6)]Man(a1-6)[Gal(b1-4)GlcNAc(b1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-6)]Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc+"+ NeuAc(a2-3)"
- N-Linked / Complex / NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-2)Man(a1-6)[Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-4)]Man(a1-3)]Man(b1-4)GlcNAc(b1-4)GlcNAc+"+ NeuAc(a2-?)"
- N-Linked / Complex / NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-4)[NeuAc(a2-6)Gal(b1-4)GlcNAc(b1-2)]Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-6)[Gal(b1-4)GlcNAc(b1-2)]Man(a1-6)[NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / NeuAc(a2-6)Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-4)]Man(a1-3)[NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / NeuAc(a2-6)Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-4)]Man(a1-3)[NeuAc(a2-6)Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / NeuAc(a2-6)Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-6)]Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc+"+ NeuAc(a2-3)"
- N-Linked / Complex / NeuAc(a2-?)Gal(b1-?)GlcNAc(?1-?)[NeuAc(a2-?)Gal(b1-?)GlcNAc(?1-?)]Man(a1-?)[Gal(b1-?)GlcNAc(?1-?)Man(a1-?)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / Structure 1479
- N-Linked / Complex / Structure 2391
- N-Linked / Complex / Structure 2691
- N-Linked / Complex / NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-4)[Gal(b1-4)GlcNAc(b1-2)]Man(a1-3)[NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / Structure 9319
- N-Linked / Complex / Structure 9462
- N-Linked / Complex / Structure 9821
- N-Linked / Complex / Structure 10038
- N-Linked / Complex / Structure 10438
- N-Linked / Complex / Structure 10456
- N-Linked / Complex / Structure 10501
- N-Linked / Complex / Structure 10612
- N-Linked / Complex / Structure 10693
- N-Linked / Complex / Structure 10898
- N-Linked / Complex / Structure 10908
- N-Linked / Complex / Structure 10926
- N-Linked / Complex / Structure 10932
- N-Linked / Complex / Structure 11148
Reported structure
- Hex:6 HexNAc:5 NeuAc:2 (avg mass : 2589.3605 )
Composition
- Cancer, breast (DOID:1612)
- Colon adenocarcinoma (DOID:234)
- Control/Healthy
- COVID-19 (DOID:0080600)
- Diabetes Mellitus, Non-insulin dependent (DOID:9352)
- Esophageal cancer (DOID:5041)
- Familial hepatic adenoma (DOID:111366)
- Hypercholesterolemia, Familial (DOID:13810)
- Maturity-onset diabetes of the young type 3 (DOID:0111102)
- Mixed phenotype acute leukemia (DOID:9953)
- Multiple myeloma (DOID:9538)
- Prostate cancer (DOID:10283)
- T-cell childhood acute lymphocytic leukemia (DOID:0080145)
Disease
- Glycoproteome remodeling in MLL-rearranged B-cell precursor acute lymphoblastic leukemia. (2021 - Oliveira T, Zhang M, Joo EJ, Abdel-Azim H, Chen CW, Yang L, Chou CH, Qin X, Chen J, Alagesan K, Almeida A, Jacob F, Packer NH, von Itzstein M, Heisterkamp N, Kolarich D) / Status : Reviewed
- Carcinoembryonic antigen glycosylation (2021 - Kolarich D) / Status : Reviewed
- Aberrant sialylation in a patient with a HNF1α variant and liver adenomatosis (2021 - Luisa Sturiale, Marie-Cécile Nassogne, Angelo Palmigiano, Angela Messina, Immacolata Speciale, Rosangela Artuso, Gaetano Bertino, Nicole Revencu, Xavier Stephénne, Cristina De Castro, Gert Matthijs, Rita Barone, Jaak Jaeken, Domenico Garozzo) / Status : Reviewed
- Toward robust N-glycomics of various tissue samples that may contain glycans with unknown or unexpected structures. (2021 - Suzuki N, Abe T, Hanzawa K, Natsuka S) / Status : Reviewed
- Community evaluation of glycoproteomics informatics solutions reveals high-performance search strategies for serum glycopeptide analysis (2021 - Rebeca Kawahara, Anastasia Chernykh, Kathirvel Alagesan, Marshall Bern, Weiqian Cao, Robert J. Chalkley, Kai Cheng, Matthew S. Choo, Nathan Edwards, Radoslav Goldman, Marcus Hoffmann, Yingwei Hu, Yifan Huang, Jin Young Kim, Doron Kletter, Benoit Liquet, Mingqi Liu, Yehia Mechref, Bo Meng, Sriram Neelamegham, Terry Nguyen-Khuong, Jonas Nilsson, Adam Pap, Gun Wook Park, Benjamin L. Parker, Cassandra L. Pegg, Josef M. Penninger, Toan K. Phung, Markus Pioch, Erdmann Rapp, Enes Sakalli, Miloslav Sanda, Benjamin L. Schulz, Nichollas E. Scott, Georgy Sofronov, Johannes Stadlmann, Sergey Y. Vakhrushev, Christina M. Woo, Hung-Yi Wu, Pengyuan Yang, Wantao Ying, Hui Zhang, Yong Zhang, Jingfu Zhao, Joseph Zaia, Stuart M. Haslam, Giuseppe Palmisano, Jong Shin Yoo, Göran Larson, Kai-Hooi Khoo, Katalin F. Medzihradszky, Daniel Kolarich, Nicolle H. Packer, Morten Thaysen-Andersen) / Status : Reviewed
- Virus-Receptor Interactions of Glycosylated SARS-CoV-2 Spike and Human ACE2 Receptor (2020 - Peng Zhao, Jeremy L. Praissman, Oliver C. Grant, Yongfei Cai, Tianshu Xiao, Katelyn E. Rosenbalm, Kazuhiro Aoki, Benjamin P. Kellman, Robert Bridger, Dan H. Barouch, Melinda A. Brindley, Nathan E. Lewis, Michael Tiemeyer, Bing Chen, Robert J. Woods, Lance Wells) / Status : Reviewed
- Site-specific N-glycosylation Characterization of Recombinant SARS-CoV-2 Spike Proteins using High-Resolution Mass Spectrometry (2020 - Yong Zhang, Wanjun Zhao, Yonghong Mao, Shisheng Wang, Yi Zhong, Tao Su, Meng Gong, Xiaofeng Lu, Jingqiu Cheng, Hao Yang) / Status : Reviewed
- Site-specific glycan analysis of the SARS-CoV-2 spike (2020 - Yasunori Watanabe, Joel D. Allen, Daniel Wrapp, Jason S. McLellan, Max Crispin) / Status : Unreviewed
- Comprehensive characterization of N- and O- glycosylation of SARS-CoV-2 human receptor angiotensin converting enzyme 2. (2020 - Asif Shajahan, Stephanie Archer-Hartmann, Nitin T. Supekar, Anne S. Gleinich, Christian Heiss, and Parastoo Azadi) / Status : Reviewed
- Cysteine Aminoethylation Enables the Site-Specific Glycosylation Analysis of Recombinant Human Erythropoietin using Trypsin (2020 - Steffen Lippold, Alexander Büttner, Matthew S.F. Choo, Michaela Hook, Coen J. de Jong, Terry Nguyen-Khuong, Markus Haberger, Dietmar Reusch, Manfred Wuhrer, Noortje de Haan) / Status : Reviewed
- Quantitative Longitudinal Inventory of the N-Glycoproteome of Human Milk from a Single Donor Reveals the Highly Variable Repertoire and Dynamic Site-Specific Changes (2020 - Jing Zhu, Yu-Hsien Lin, Kelly A Dingess, Marko Mank, Bernd Stahl, Albert J R Heck) / Status : Reviewed
- Capturing site-specific heterogeneity with large-scale N-glycoproteome analysis (2019 - Nicholas M. Riley, Alexander S. Hebert, Michael S. Westphall & Joshua J. Coon ) / Status : Unreviewed
- Glycoproteomic Analysis of MGL-Binding Proteins on Acute T-Cell Leukemia Cells. (2019 - Martina Pirro, Esmee Schoof, Sandra J. van Vliet, Yoann Rombouts, Alexandre Stella, Arnoud de Ru, Yassene Mohammed, Manfred Wuhrer, Peter A. van Veelen, Paul J. Hensbergen) / Status : Reviewed
- A novel, ultrasensitive approach for quantitative carbohydrate composition and linkage analysis using LC-ESI ion trap tandem mass spectrometry (2019 - Kathirvel Alagesan, Daniel Varon Silva, Peter H Seeberger, Daniel Kolarich) / Status : Reviewed
- Reanalysis of global proteomic and phosphoproteomic data identified a large number of glycopeptides (2018 - Yingwei Hu, Punit Shah, David J. Clark, Minghui Ao, Hui Zhang) / Status : Unreviewed
- Large-scale intact glycopeptide identification by Mascot database search (2018 - Ravi Chand Bollineni, Christian Jeffrey Koehler, Randi Elin Gislefoss, Jan Haug Anonsen, Bernd Thiede) / Status : Unreviewed
- Distinct urinary glycoprotein signatures in prostate cancer patients (2018 - Rebeca Kawahara, Fabio Ortega, Livia Rosa-Fernandes, Vanessa Guimarães, Daniel Quina, Willian Nahas, Veit Schwämmle, Miguel Srougi, Katia R.M. Leite, Morten Thaysen-Andersen, Martin R. Larsen and Giuseppe Palmisano) / Status : Unreviewed
- Site-Specific Profiling of Serum Glycoproteins Using N-Linked Glycan and Glycosite Analysis Revealing Atypical N-Glycosylation Sites on Albumin and α-1B-Glycoprotein (2018 - Shisheng Sun, Yingwei Hu, Li Jia, Shadi Toghi Eshghi, Yang Liu, Punit Shah, Hui Zhang) / Status : Unreviewed
- Site-specific N-glycosylation analysis of human factor XI: Identification of a noncanonical NXC glycosite (2014 - Faid V, Denguir N, Chapuis V, Bihoreau N, Chevreux G) / Status : Reviewed
- Computational framework for identification of intact glycopeptides in complex samples (2014 - Mayampurath A, Yu CY, Song E, Balan J, Mechref Y, Tang H.) / Status : Reviewed
- In-depth analysis of site-specific N-glycosylation in vitronectin from human plasma by tandem mass spectrometry with immunoprecipitation (2014 - Hwang H, Lee JY, Lee HK, Park GW, Jeong HK, Moon MH, Kim JY, Yoo JS.) / Status : Reviewed
- Comparison of sialylated N-glycopeptide levels in serum of pancreatic cancer patients, acute pancreatitis patients, and healthy controls (2014 - Kontro H, Joenväärä S, Haglund C, Renkonen R) / Status : Reviewed
- Efficient and accurate glycopeptide identification pipeline for high-throughput site-specific N-glycosylation analysis (2014 - Liu M, Zhang Y, Chen Y, Yan G, Shen C, Cao J, Zhou X, Liu X, Zhang L, Shen H, Lu H, He F, Yang P) / Status : Reviewed
- Selective glycopeptide profiling by acetone enrichment and LC/MS (2014 - Takakura D, Harazono A, Hashii N, Kawasaki N) / Status : Reviewed
- Glycoproteomic analysis of the secretome of human endothelial cells (2013 - Yin X, Bern M, Xing Q, Ho J, Viner R, Mayr M.) / Status : Reviewed
- Quantitative analysis of site-specific N-glycans on sera haptoglobin β chain in liver diseases. (2013 - Zhang S, Jiang K, Sun C, Lu H, Liu Y.) / Status : Reviewed
- Exploring site-specific N-glycosylation microheterogeneity of haptoglobin using glycopeptide CID tandem mass spectra and glycan database search (2013 - Chandler KB1, Pompach P, Goldman R, Edwards N.) / Status : Reviewed
- Site-specific glycoprofiling of N-linked glycopeptides using MALDI-TOF MS: strong correlation between signal strength and glycoform quantities. (2009 - Thaysen-Andersen M, Mysling S, Højrup P) / Status : Reviewed
- Simultaneous glycosylation analysis of human serum glycoproteins by high-performance liquid chromatography/tandem mass spectrometry (2008 - Harazono A, Kawasaki N, Itoh S, Hashii N, Matsuishi-Nakajima Y, Kawanishi T, Yamaguchi T) / Status : Reviewed
- Characterization of human apolipoprotein B100 oligosaccharides in LDL subfractions derived from normal and hyperlipidemic plasma: deficiency of alpha-N-acetylneuraminyllactosyl-ceramide in light and small dense LDL particles. (2001 - Garner B, Harvey DJ, Royle L, Frischmann M, Nigon F, Chapman MJ, Rudd PM) / Status : Reviewed
- Characterisation of horse dander allergen glycoproteins using amino acid and glycan structure analyses. A mass spectrometric method for glycan chain analysis of glycoproteins separated by two-dimensional electrophoresis. (2000 - Bulone V, Rademaker G, Pergantis S, Krogstad-Johnsen T, Smestad-Paulsen B, Thomas-Oates J) / Status : Reviewed
- Hierarchy of post-translational modifications involved in the circulatory longevity of glycoproteins. Demonstration of concerted contributions of glycan sialylation and subunit assembly to the pharmacokinetic behavior of bovine acetylcholinesterase. (2000 - Kronman C, Chitlaru T, Elhanany E, Velan B, Shafferman A) / Status : Reviewed
- Structural analysis of N-linked sugar chains of human blood clotting factor IX. (2000 - Makino Y, Omichi K, Kuraya N, Ogawa H, Nishimura H, Iwanaga S, Hase S) / Status : Reviewed
- Structural determination of N-linked carbohydrates by matrix-assisted laser desorption/ionization-mass spectrometry following enzymatic release within sodium dodecyl sulfate-polyacrylamide electrophoresis gels: application to species-specific glycosylation of alpha1-acid glycoprotein. (1998 - Kuster B, Hunter A, Wheeler S, Dwek R, Harvey D) / Status : Reviewed
- Detailed oligosaccharide structures of human integrin alpha 5 beta 1 analyzed by a three-dimensional mapping technique. (1996 - Nakagawa H, Zheng M, Hakomori S, Tsukamoto Y, Kawamura Y, Takahashi N) / Status : Reviewed
- Identification of neutral and sialyl N-linked oligosaccharide structures from human serum glycoproteins using three kinds of high-performance liquid chromatography. (1995 - Nakagawa H, Kawamura Y, Kato K, Shimada I, Arata Y, Takahashi N) / Status : Reviewed
- A strategy for the mapping of N-glycans by high-performance capillary electrophoresis. (1994 - Hermentin P, Doenges R, Witzel R, Hokke C, Vliegenthart J, Kamerling J, Conradt H, Nimtz M, Brazel D) / Status : Reviewed
- Structures of sugar chains of hen egg yolk riboflavin-binding protein. (1993 - Tarutani M, Norioka N, Mega T, Hase S, Ikenaka T) / Status : Reviewed
- Structural study of the N-linked oligosaccharides of hepatocyte growth factor by two-dimensional sugar mapping. (1993 - Hara H, Nakae Y, Sogabe T, Ihara I, Ueno S, Sakai H, Inoue H, Shimizu S, Nakamura T, Shimizu N) / Status : Reviewed
- Detailed structural analysis of asparagine-linked oligosaccharides of the nicotinic acetylcholine receptor from Torpedo californica. (1992 - Shoji H, Takahashi N, Nomoto H, Ishikawa M, Shimada I, Arata Y, Hayashi K) / Status : Reviewed
- The Asn-linked carbohydrate chains of human Tamm-Horsfall glycoprotein of one male. Novel sulfated and novel N-acetylgalactosamine-containing N-linked carbohydrate chains. (1992 - Hard K, Van Zadelhoff G, Moonen P, Kamerling J, Vliegenthart F) / Status : Reviewed
- Structure determination of the glycans of human-serum alpha 1-antichymotrypsin using 1H-NMR spectroscopy and deglycosylation by N-glycanase. (1991 - Laine A, Hachulla E, Strecker G, Michalski J, Wieruszeski J) / Status : Reviewed
- Oligosaccharides at individual glycosylation sites in glycoprotein 71 of Friend murine leukemia virus. (1990 - Geyer R, Dabrowski J, Dabrowski U, Linder D, Schlter M, Schott H, Stirm S) / Status : Reviewed
- Isolation and structure determination of the intact sialylated N-linked carbohydrate chains of recombinant human follitropin expressed in Chinese hamster ovary cells. (1990 - Hard K, Mekking A, Damm J, Kamerling J, de Boer W, Wijnands R, Vliegenthart J) / Status : Reviewed
- The asparagine-linked oligosaccharides on bovine fetuin. Structural analysis of N-glycanase-released oligosaccharides by 500-megahertz 1H NMR spectroscopy. (1988 - Green E, Adelt G, Baenziger J, Wilson S, Van Halbeek H) / Status : Reviewed
Reference
- ADAM DEC1 / Homo sapiens
- ADAMTS-like protein 2 / Homo sapiens
- Adenosine deaminase 2 / Homo sapiens
- Adhesion G protein-coupled receptor F5 / Homo sapiens
- Adhesion G protein-coupled receptor L4 / Homo sapiens
- Adhesion G-protein coupled receptor D1 / Homo sapiens
- Alpha-1-acid glycoprotein 1 / Homo sapiens
- Alpha-1-acid glycoprotein 2 / Homo sapiens
- Alpha-1-antichymotrypsin / Homo sapiens
- Alpha-1-antitrypsin / Homo sapiens
- Alpha-1b-glycoprotein / Homo sapiens
- Alpha-2-HS-glycoprotein / Homo sapiens
- Alpha-2-macroglobulin / Homo sapiens
- Alpha-n-acetylglucosaminidase / Homo sapiens
- Angiopoietin-1 receptor / Homo sapiens
- Angiopoietin-related protein 4 / Homo sapiens
- Angiotensin-converting enzyme / Homo sapiens
-
Angiotensin-converting enzyme 2 / Homo sapiens
- Undefined site
- Angiotensinogen / Homo sapiens
- Apolipoprotein (a) / Homo sapiens
- Apolipoprotein B-100 / Homo sapiens
- Apolipoprotein D / Homo sapiens
- Apolipoprotein F / Homo sapiens
- Asialoglycoprotein receptor 2 / Homo sapiens
- Attractin / Homo sapiens
- Basement membrane-specific heparan sulfate proteoglycan core protein / Homo sapiens
- Beta-2-glycoprotein 1 / Homo sapiens
- Beta-Ala-His dipeptidase / Homo sapiens
- Biotinidase / Homo sapiens
- Bone marrow stromal antigen 2 / Homo sapiens
- C4b-binding protein alpha chain / Homo sapiens
- C4b-binding protein beta chain / Homo sapiens
- Cadherin-13 / Homo sapiens
- Carboxypeptidase b2 / Homo sapiens
- Carboxypeptidase N subunit 2 / Homo sapiens
-
Carcinoembryonic antigen-related cell adhesion molecule 5 / Homo sapiens
- Undefined site
- Catalase / Homo sapiens
- Cathepsin D / Homo sapiens
- Cathepsin L1 / Homo sapiens
- CD109 antigen / Homo sapiens
- CD166 antigen / Homo sapiens
- CD276 antigen / Homo sapiens
- CD44 antigen / Homo sapiens
- CD48 antigen / Homo sapiens
- Ceruloplasmin / Homo sapiens
- Cholesteryl ester transfer protein / Homo sapiens
- Clusterin / Homo sapiens
-
Coagulation factor IX / Homo sapiens
- Undefined site
- Coagulation factor VIII / Homo sapiens
- Coagulation factor XI / Homo sapiens
- Coagulation factor XIII B chain / Homo sapiens
- Collagen alpha-3(VI) chain / Homo sapiens
- Complement factor h / Homo sapiens
- Complement factor H-related protein 1 / Homo sapiens
- Complement factor H-related protein 3 / Homo sapiens
- Complement factor H-related protein 4 / Homo sapiens
- Complement factor i / Homo sapiens
- Contactin-3 / Homo sapiens
- Contactin-4 / Homo sapiens
- Corticosteroid-binding globulin / Homo sapiens
- Decorin / Homo sapiens
- Desmoglein-2 / Homo sapiens
- Ecto-ADP-ribosyltransferase 4 / Homo sapiens
- Endoplasmic reticulum aminopeptidase 2 / Homo sapiens
- Endothelial cell-selective adhesion molecule / Homo sapiens
- Endothelin-converting enzyme 1 / Homo sapiens
- Epidermal growth factor receptor / Homo sapiens
- Epididymis-specific alpha-mannosidase / Homo sapiens
- Erythropoietin / Homo sapiens
- Extracellular matrix protein 1 / Homo sapiens
- Extracellular sulfatase Sulf-2 / Homo sapiens
- Fibrillin-1 / Homo sapiens
- Fibroleukin / Homo sapiens
-
Follitropin, alpha and beta chains / Homo sapiens
- Undefined site
- Frizzled-6 / Homo sapiens
- G-protein coupled receptor 126 / Homo sapiens
- Galectin-3-binding protein / Homo sapiens
- Gamma-glutamyltranspeptidase 1 / Homo sapiens
- Glutaminase kidney isoform, mitochondrial / Homo sapiens
- Glycocalicin / Homo sapiens
- Haptoglobin / Homo sapiens
- Hemopexin / Homo sapiens
- Heparin cofactor 2 / Homo sapiens
- Hepatocyte growth factor / Homo sapiens
- Hepatocyte growth factor activator / Homo sapiens
- Hepatocyte growth factor receptor / Homo sapiens
- HLA class II histocompatibility antigen, DP alpha 1 chain / Homo sapiens
- Homeobox protein Hox-B3 / Homo sapiens
- IgGFc-binding protein / Homo sapiens
-
Immunoglobulin alpha-2 heavy chain (secretory) - heavy chain 1 / Homo sapiens
- Undefined site
-
Immunoglobulin alpha-2 heavy chain (secretory) - heavy chain 2 / Homo sapiens
- Undefined site
-
Immunoglobulin alpha-2 heavy chain (secretory) - heavy chain 3 / Homo sapiens
- Undefined site
- Immunoglobulin heavy constant alpha 1 / Homo sapiens
-
Immunoglobulin heavy constant alpha 1 - heavy chain 1 / Homo sapiens
- Undefined site
-
Immunoglobulin heavy constant alpha 1 - heavy chain 2 / Homo sapiens
- Undefined site
-
Immunoglobulin heavy constant alpha 2 / Homo sapiens
- Undefined site
- Asn-205
-
Immunoglobulin heavy constant alpha 2 - heavy chain 1 / Homo sapiens
- Undefined site
-
Immunoglobulin heavy constant delta / Homo sapiens
- Undefined site
-
Immunoglobulin heavy constant delta - heavy chain 2 / Homo sapiens
- Undefined site
-
Immunoglobulin heavy constant epsilon - heavy chain 1 / Homo sapiens
- Undefined site
-
Immunoglobulin heavy constant epsilon - heavy chain 2 / Homo sapiens
- Undefined site
- Immunoglobulin heavy constant gamma 2 / Homo sapiens
-
Immunoglobulin heavy constant mu / Homo sapiens
- Undefined site
- Asn-46
- Integrin alpha-5 / Homo sapiens
-
Integrin alpha-5/beta-1 / Homo sapiens
- Undefined site
- Inter-alpha-trypsin inhibitor heavy chain h1 / Homo sapiens
- Inter-alpha-trypsin inhibitor heavy chain h2 / Homo sapiens
- Inter-alpha-trypsin inhibitor heavy chain h4 / Homo sapiens
- Intercellular adhesion molecule 2 / Homo sapiens
- Interleukin-1 receptor accessory protein / Homo sapiens
- Interleukin-1 receptor-like 1 / Homo sapiens
- Interleukin-6 receptor subunit beta / Homo sapiens
- Junction plakoglobin / Homo sapiens
- Kallistatin / Homo sapiens
- Keratin, type I cytoskeletal 9 / Homo sapiens
- Kininogen-1 / Homo sapiens
- Lactotransferrin / Homo sapiens
- Laminin subunit alpha-2 / Homo sapiens
- Laminin subunit alpha-4 / Homo sapiens
- Laminin subunit gamma-1 / Homo sapiens
- Latent transforming growth factor beta binding protein 1 / Homo sapiens
- Leptin receptor / Homo sapiens
- Leucine-rich repeat-containing protein 15 / Homo sapiens
- Leucyl-cystinyl aminopeptidase / Homo sapiens
- Lipopolysaccharide-binding protein / Homo sapiens
- Lumican / Homo sapiens
- Lysosome-associated membrane glycoprotein 1 / Homo sapiens
- Lysosome-associated membrane glycoprotein 2 / Homo sapiens
- Macrophage colony-stimulating factor 1 receptor / Homo sapiens
- Maltase-glucoamylase, intestinal / Homo sapiens
- Mannan-binding lectin serine protease 1 / Homo sapiens
- Mesothelin / Homo sapiens
- Mimecan / Homo sapiens
- Multimerin-1 / Homo sapiens
- Multimerin-2 / Homo sapiens
- Multiple epidermal growth factor-like domains protein 8 / Homo sapiens
- Myeloperoxidase / Homo sapiens
- Neogenin / Homo sapiens
- Neuron navigator 2 / Homo sapiens
- Noelin / Homo sapiens
- Oncoprotein-induced transcript 3 protein / Homo sapiens
- Oncostatin-M-specific receptor subunit beta / Homo sapiens
- Peroxidasin homolog / Homo sapiens
- Phosphatidylinositol-glycan-specific phospholipase D / Homo sapiens
- Plasma protease c1 inhibitor / Homo sapiens
- Plasma serine protease inhibitor / Homo sapiens
- Plasminogen / Homo sapiens
- Platelet endothelial cell adhesion molecule / Homo sapiens
- Platelet glycoprotein V / Homo sapiens
- Platelet-derived growth factor subunit b / Homo sapiens
- Plexin-B1 / Homo sapiens
- Plexin-B2 / Homo sapiens
- Polymeric immunoglobulin receptor / Homo sapiens
- Prolactin-inducible protein / Homo sapiens
- Prolargin / Homo sapiens
- Prolow-density lipoprotein receptor-related protein 1 / Homo sapiens
- Prostaglandin-h2 d-isomerase / Homo sapiens
- Protein heg homolog 1 / Homo sapiens
- Prothrombin / Homo sapiens
- Receptor-type tyrosine-protein phosphatase C / Homo sapiens
- Receptor-type tyrosine-protein phosphatase gamma / Homo sapiens
- Receptor-type tyrosine-protein phosphatase kappa / Homo sapiens
- Receptor-type tyrosine-protein phosphatase mu / Homo sapiens
- Scavenger receptor cysteine-rich type 1 protein M130 / Homo sapiens
- Secretogranin-3 / Homo sapiens
- Selenoprotein P / Homo sapiens
- Semaphorin-4D / Homo sapiens
- Serotransferrin / Homo sapiens
- Serum paraoxonase/arylesterase 1 / Homo sapiens
- Tenascin-N / Homo sapiens
- Tensin-2 / Homo sapiens
- Thrombospondin-1 / Homo sapiens
- Thyroxine-binding globulin / Homo sapiens
- Trem-like transcript 2 protein / Homo sapiens
- Tumor necrosis factor receptor superfamily member 21 / Homo sapiens
- Type 2 lactosamine alpha-2,3-sialyltransferase / Homo sapiens
- Tyrosine-protein kinase Mer / Homo sapiens
- Tyrosine-protein kinase receptor TYRO3 / Homo sapiens
- Tyrosine-protein kinase receptor UFO / Homo sapiens
-
Uncharacterized protein from Blood Serum / Homo sapiens
- Undefined site
- Uromodulin / Homo sapiens
- Vascular cell adhesion protein 1 / Homo sapiens
- Vitronectin / Homo sapiens
- Voltage-dependent calcium channel subunit alpha-2/delta-1 / Homo sapiens
- Von willebrand factor / Homo sapiens
- Zinc-alpha-2-glycoprotein / Homo sapiens
-
Acetylcholinesterase / Bos taurus
- Undefined site
-
Alpha-1-acid glycoprotein / Bos taurus
- Undefined site
- Alpha-2-hs-glycoprotein / Bos taurus
-
Alpha-1-acid glycoprotein / Canis lupus familiaris
- Undefined site
-
Uncharacterized protein from Dander / Equus caballus
- Undefined site
- Synaptophysin-like protein 1 / Mus musculus
-
Alpha-1-acid glycoprotein / Ovis aries
- Undefined site
-
Riboflavin-binding protein / Gallus gallus
- Undefined site
-
Acetylcholine receptor protein / Torpedo californica
- Undefined site
- Envelope glycoprotein / Friend murine leukemia virus
- Recombinant Spike glycoprotein (FreeStyle 293-F) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- Recombinant Spike glycoprotein (HEK293) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
Reported glycosite
- NPNATSSSSQDPESLQDR (18aa)
- CANLVPVPITNATLDR (16aa)
- LVPVPITNATLDQITGK (17aa)
- LVPVPITNATLDR (13aa)
- VTACHSSQPNATLYK (15aa)
- MAYNMTFFPNLM (12aa)
- GTQAEESPFVGNPGNITGAR (20aa)
- NNSDISSTR (9aa)
- HLVIHNESTCEQLAK (15aa)
- NLSMPLLPADFHK (13aa)
- WQMNFTVR (8aa)
- WFSAGLASNSSWLR (14aa)
- KWFYIASAFRNEEYNKS (17aa)
- FNYSTAHSAGLTLIWYWTR (19aa)
- AFNSTLPTMAQMEK (14aa)
- YETTNK (6aa)
- LLHGDPGEEDGAELDLNMTR (20aa)
- CSDGWSFDATTLDDNGTMLFFK (22aa)
- NVTHLLQQELTEAQK (15aa)
- CIQANYSLMENGK (13aa)
- SLNENITVPDTK (12aa)
- CIQANYSIMENGK (13aa)
- MLFVEPILEVSSLPTTNSTTNSATK (25aa)
- SVQEIQATFFYFTPNKTEDTIFLR (24aa)
- SVQEIQATFFYFTPNK (16aa)
- NQTVTATFGYPFR (13aa)
- YFTPNKTEDTIFLR (14aa)
- KSVQEIQATFFYFTPNKT (18aa)
- QVHFFVNASDVDNVK (15aa)
- AFGSNPNLTK (10aa)
- TTENYPNAGLIMNYCR (16aa)
- TLPGGNQCIVPICR (14aa)
- AFITNFSMIIDGMTYPGIIK (20aa)
- EGYSNISYIVVNHQGISSR (19aa)
- DDVLFYNISSMK (12aa)
- NNATVHEQVGGPSLTSDLQAQSK (23aa)
- KNNATVHEQVGGPSLTSDLQAQSKG (25aa)
- KKKEDALNETRE (12aa)
- KKKEDALNETRESETKL (17aa)
- NNATVHEQVGGPSITSDIQAQSK (23aa)
- AFENVTDLQWLILDHNLLENSK (22aa)
- AIVNFTR (7aa)
- VVNITMVALK (10aa)
- ICNQNSSNPNQR (12aa)
- LNLSENYTLSISNAR (15aa)
- QNQCFYNSSYLNVQR (15aa)
- LSLGAHNTTLTEILK (15aa)
- QDQCIYNTTYLNVQR (15aa)
- QNQCFYNSSYINVQR (15aa)
- QDQCIYNTTYINVQR (15aa)
- AQLLQGLGFNLTER (14aa)
- AQIIQGIGFNITER (14aa)
- ADGTVNQIEGEATPVNITEPAKIEVK (26aa)
- ADGTVNQIEGEATPVNLTEPAK (22aa)
- RPTGEVYDIEIDTLETTCHVLDPTPLANCSVR (32aa)
- IAVQFGPGFSWIANFTK (17aa)
- TGYANVTIYK (10aa)
- ENDTHCIDFSYLLYSQK (17aa)
- ELPGVCNETMMALWEECKPCLK (22aa)
- GHTLTLNFTR (10aa)
- FLNNGTCTAEGK (12aa)
- TAIFPDIIAQGNASIR (16aa)
- TFYWDFYTNR (10aa)
- SIDVSIQNVSVVFK (14aa)
- FNLTETSEAEIHQSFQHLLR (20aa)
- FNITETSEAEIHQSFQHIIR (20aa)
- ADTHDEIIEGINFNITEIPEAQIHEGFQEIIR (32aa)
- DIVEYYNDSNGSHVLQGR (18aa)
- LAFATMFNSSEQSQK (15aa)
- TQSLLIVNNATNVVIK (16aa)
- KLHINHNNLTESVGPLPK (18aa)
- LHINHNNLTESVGPLPK (17aa)
- TLNQSSDELQLSMGNAMFVK (20aa)
- TLNQSSDELQLSMGN (15aa)
- TINQSSDEIQISMGNAMFVK (20aa)
- RTLNQSSDELQLSMGNAMFVKE (22aa)
- FGCEIENNR (9aa)
- VNNGPLGNPIWNISGDPTR (19aa)
- RGLSFDVSLEVSQGPGLLNDTKV (23aa)
- KEHEGAIYPDNTTDFQRADDKV (22aa)
- EHEGAIYPDNTTDFQR (16aa)
- GDNVNISFK (9aa)
- YPHKPEINSTTHPGADLQENFCR (23aa)
- YLNEYNGSYVPPGWKEWVGLLK (22aa)
- FFPPVLNVTWLCNGELVTEGVAESLFLPR (29aa)
- FSPATHPSEGLEENYCR (17aa)
- GNETLHYETFGK (12aa)
- LCPDCPLLAPLNDSR (15aa)
- VCQDCPIIAPINDTR (15aa)
- KVCQDCPLLAPLNDTRV (17aa)
- VCQDCPLLAPLNDTR (15aa)
- ETHLETNFTLK (11aa)
- IGSFEGIVNITFIHIQHNR (19aa)
- VYKPSAGNNSLYR (13aa)
- RVYKPSAGNNSLYRD (15aa)
- VYSSANNCTFE (11aa)
- QQLQGVNVCGGR (12aa)
- HGIQYFNNNTQHSSLFMLNEVK (22aa)
- NGSLFAFR (8aa)
- HGIQYFNNNTQHSSLFTLNEVK (22aa)
- FVACQMELLHSNGSQR (16aa)
- VQNVTEFDDSLLR (13aa)
- VVHAVEVALATFNAESNGSYLQLVEISR (28aa)
- AALAAFNAQNNGSNFQLEEISR (22aa)
- NAQNNGSNFQLEEISR (16aa)
- LSDLSINSTECLHVHCR (17aa)
- LPEMAQPVDPAHNVSR (16aa)
- FGYILHTDNR (10aa)
- EGDHEFLEVPEAQEDVEATFPVHQPGNYSCSYR (33aa)
- LLDLSGNNLTHLPK (14aa)
- MVSHHNITTGATIINEQWIITTAK (24aa)
- MVSHHNLTTGATLINEQWLLTTAK (24aa)
- EHAVFTSNQEEQDPANHTCGVK (22aa)
- KMVSHHNLTTGATLINEQWLLTTAKN (26aa)
- QVLFLDTVYGNCSTHFTVK (19aa)
- SWPAVGNCSSALR (13aa)
- SWPAVGNCSSAIR (13aa)
- NFSCLAVLDLMSR (13aa)
- TMQNTSDLDTAR (12aa)
- ITYSIVQTNCSK (12aa)
- TPLTANITK (9aa)
- NGTVCLSPPCTLAR (14aa)
- NLFLNHSENATAK (13aa)
- KNLFLNHSENATAKD (15aa)
- IGGWNITGPWAK (12aa)
- IADTNITSIPQGIPPSITEIHIDGNK (26aa)
- GSLSLTNLSSSMAGVYVCK (19aa)
- KLNNLTFLYLDHNALESVPLNLPESLR (27aa)
- NLCEAMENFMQQLK (14aa)
- LNNLTFLYLDHNALESVPLNLPESLR (26aa)
- SPDVINGSPISQK (13aa)
- ASISCTVENETIGVWRPSPPTCEK (24aa)
- YSVANDTGFVDIPK (14aa)
- NTVISVNPSTK (11aa)
- VEMANLLNLSER (12aa)
- CNTAAPMWLNGTHPSSDEGIVSR (23aa)
- NTTVRVPMMLQDQE (14aa)
- VVLHPNYSQVDIGLIK (16aa)
- KVVLHPNYSQVDIGLIKL (18aa)
- VVIHPNYSQVDIGIIK (16aa)
- NISDGFDGIPDNVDAALALPAHSYSGR (27aa)
- FEDGVLDPDYPRNISDGFDGIPDNVDAALALPAHSYSGR (39aa)
- NLSVEDAAR (9aa)
- SFNQSLHSLTQAIR (14aa)
- TTEFDTNSTDIALK (14aa)
- HANWTLTPLK (10aa)
- IGNWSAMPSCK (11aa)
- VLSNNSDANLELINTWVAK (19aa)
- LGNWSAMPSCK (11aa)
- VASVININPNTTHSTGSCR (19aa)
- VINMSYHPR (9aa)
- IININPNK (8aa)
- VFPQVNVTK (9aa)
- IGISFNSISAVDNGSIANTPHIR (23aa)
- VVGVPYQGNATALFILPSEGK (21aa)
- GSLSYLNVTR (10aa)
- QVLDNLTMEK (10aa)
- DANISQPETTK (11aa)
- YIGNATAIFFIPDEGK (16aa)
- YTGNASALFILPDQDK (16aa)
- YLGNATAIFFLPDEGK (16aa)
- KYTGNASALFILPDQDKM (18aa)
- KYLGNATAIFFLPDEGKL (18aa)
- DTCPPLMLYNPTTYQMDVNPEGK (23aa)
- LNSSTIK (7aa)
- YSENSTTVIR (10aa)
- ICDLLVANNHFAHFFAPQNLTNMNK (25aa)
- NSFNISNLLVLHLSHNR (17aa)
- LNAENNATFYFK (12aa)
- INAENNATFYFK (12aa)
- GVSNGTHVNILFSLK (15aa)
- EVLSSNVSWR (10aa)
- NVTAEQLFLK (10aa)
- LGYNANTSILSFQAVCR (17aa)
- LWNFTMNAK (9aa)
- HVNEINATIYLLK (13aa)
- SLSEQTALNLTK (12aa)
- VTQVYAENGTVIQGSTVASVYK (22aa)
- VTQVYAENGTVLQGSTVASVYK (22aa)
- ALHALNVTWR (10aa)
- LHVGNYNGTAGDALR (15aa)
- NVSTNVFFK (9aa)
- LAGKPTHVNVSVVMAEVDGTC (21aa)
- IDNISLTVNDVR (12aa)
- NGSQAFVHWQEPR (13aa)
- NATDNISK (8aa)
- LYLGSNNLTALHPALFQNLSK (21aa)
- NPVGLIGAENATGETDPSHSK (21aa)
- VGQLQLSHNLSLVILVPQNLK (21aa)
- MINTSSIIEQINEQFNWVSR (20aa)
- NMSNQLGLLAVNQR (14aa)
- GVVVNSSVMVK (11aa)
- AGIQAFFQVQECNK (14aa)
- AGLQAFFQVQECNK (14aa)
- NCTSISGDLHILPVAFR (17aa)
- WTPNFTLHMESITFSK (16aa)
- MLANLQNISLQNNR (14aa)
- LANLTQGEDQYYLR (14aa)
- IANITQGEDQYYIR (14aa)
- RLANLTQGEDQYYLRV (16aa)
- NILDALMLNTTR (12aa)
- AANYTSSLNLPDK (13aa)
- ANLTGWDPQK (10aa)
- MMQYNVSIK (9aa)
- LVPHMNVSAVEK (12aa)
- LSVATNVSATLTFNTSK (17aa)
- LDPVSLQTLQTWNTSYPK (18aa)
- ENITAPGSDSAVFFEQGTTR (20aa)
- ENLTAPGSDSAVFFEQGTTR (20aa)
- YKGLNLTEDTYKPR (14aa)
- IDSTGNVTNELR (12aa)
- SFHNFTLCYIK (11aa)
- NVTGTPLTGDK (11aa)
- CGIVPVIAENYNK (13aa)
- CGLVPVLAENYNK (13aa)
- CGLVPVLAENYNKSDNCEDTPEAGYFAVAVVK (32aa)
- KCGLVPVLAENYNKS (15aa)
- ELLEEVGQNGSR (12aa)
- HIPGLIHNMTAR (12aa)
- GSTPRNDPSVSVDYNTTEPAVR (22aa)
- ALPQPQNVTSLLGCTH (16aa)
- AIPQPQNVTSIIGCTH (16aa)
- TPASDPHGDNLTYSVFYTK (19aa)
- DFTLNETVNSIFAQGAPR (18aa)
- NFTEVHPDYGSHIQALLDK (19aa)
- ANGTTHLVVTEPTR (14aa)
- LETTVNYTDSQRPICLPSK (19aa)
- YIPYTLYSVFNPSDHDLVLIR (21aa)
- TAGWNIPMGIIFNQTGSCK (19aa)
- KWNNTGCQALPSQDEGPSKA (20aa)
- FALLMTNCYATPSSNATDPLK (21aa)
- LPTQNITFQTESSVAEQEAEFQSPK (25aa)
- IPTQNITFQTESSVAEQEAEFQSPK (25aa)
- SCSLEGNPVACINLSFCLNASGK (23aa)
- LCNNPTPQFGGK (12aa)
- ALSQQNVSMDLATFMK (16aa)
- HGVIISSTVDTYENGSSVEYR (21aa)
- LGYNANTSVLSFQAVCR (17aa)
- LNVEAANWTVR (11aa)
- NGSFITK (7aa)
- INNLTVSLEMEK (12aa)
- NQALNLSLAYSFVTPLTSMVVTK (23aa)
- WNNTPMDEALHFGHHDVFK (19aa)
- DNHSPVISYSIQAR (14aa)
- QQQHLFGSNVTDCSGNFCLFR (21aa)
- QQQHIFGSNVTDCSGNFCIFR (21aa)
- ANYNLPIMVTDSGKPPMTNITDLR (24aa)
- NCMLNENMSVCVADFGLSK (19aa)
- NMQIANHTLK (10aa)
- TEEALPEVTPANVSGGGGSK (20aa)
- NISDISENLK (10aa)
- NICFNIDSEPGK (12aa)
- NTSGMISRPAPGR (13aa)
- DFVNCSTLPALNLASWR (17aa)
- LHHLQEQNVSNAFLDKGE (18aa)
- ELHHLQEQNVSNAFLDK (17aa)
- KELHHLQEQNVSNAFLDKG (19aa)
- NESVHPFSPFEVK (13aa)
- NLNNSQSDVVSFR (13aa)
- NFTVACQHR (9aa)
- AASYTEEDENHTAK (14aa)
- DIMNDSNYIVK (11aa)
- RPASNVSASIQR (12aa)
- DNIGSQYLLNWCVQIAK (17aa)
- SAIIEFACTHNIGNCSTTAMK (21aa)
- IPCSQPPQIEHGTINSSR (18aa)
- ISEENETTCYMGK (13aa)
- ILGTEEPSNVTVK (13aa)
- SVSPTTEMVSNESVDYR (17aa)
- GNESSLWDCPAR (12aa)
- SINVTGQGFSLIQR (14aa)
- YINASFIMSYWK (12aa)
- LLIQAEQTSDGPNPCDMVK (19aa)
- QVTQSYWDTNPTR (13aa)
- NECGILADPK (10aa)
- VVNSTTGPGEHLR (13aa)
- SPYEMFGDEEVMCLNGNWTEPPQCK (25aa)
- NGTHWFV (7aa)
- NGTHWFVT (8aa)
- TLNMCFSALPSYIR (14aa)
- LHNLTTGTPAR (11aa)
- SLSSSSIGSNSTYLTSK (17aa)
- NETHNPTVK (9aa)
- NSSVVPSER (9aa)
- SSTSSIDSNISSK (13aa)
- NISQDLEK (8aa)
- YTLDPNITSAGPTK (14aa)
- ALLTNVSSVALGSR (14aa)
- ILCDNADNITR (11aa)
- IPAINQTITEANEK (14aa)
- VSNQTLSLFFTVLQDVPVR (19aa)
- NNLSLAILTLEMTGDQR (17aa)
- WTGHNVTVVQR (11aa)
- MLYGLENMTQELK (13aa)
- LNETLGTR (8aa)
- LYWTDGDNISMANMDGSNR (19aa)
- NSTTLVMHMK (10aa)
- LSAIPNDTAAK (11aa)
- DNATDSVPLR (10aa)
- GTNVCAVANGGCQQLCLYR (19aa)
- GNPGEPGLNGTTGPK (15aa)
- NESGIILLGSGGTPAPPR (18aa)
- MEACMLNGTVIGPGK (15aa)
- TAIFAFNISHVSNK (14aa)
- QNLTVTDR (8aa)
- VEGSHNSTVSLTTK (14aa)
- YDFNSSMLYSTAK (13aa)
- FEVDSPVYNATWSASLK (17aa)
- FEVDSPVYNATWSASIK (17aa)
- GVTHLNISGLK (11aa)
- TPENYPNAGLTENYCR (16aa)
Mass spectrometry observed peptide
-
- N-Linked / Complex
(avg mass : 2589.3605)
- Blood Serum (UBERON_0001977)
-
Alpha-1-acid glycoprotein / Canis lupus familiaris
- Undefined site
-
- N-Linked / Complex
(avg mass : 2589.3605)
- Blood Serum (UBERON_0001977)
-
Alpha-1-acid glycoprotein 2 / Homo sapiens
- Undefined site
-
Alpha-1-acid glycoprotein / Bos taurus
- Undefined site
-
Alpha-1-acid glycoprotein / Ovis aries
- Undefined site
-
- N-Linked / Complex
(avg mass : 2589.3605)
- Blood Serum (UBERON_0001977)
-
Alpha-2-hs-glycoprotein / Bos taurus
- Undefined site
-
- N-Linked / Complex
(avg mass : 2589.3605)
- Blood Plasma (UBERON_0001969)
- Electric Organ (UBERON_0006869)
- Ovary (UBERON_0000992) CHO (CVCL_0213)
- Control/Healthy
- A novel, ultrasensitive approach for quantitative carbohydrate composition and linkage analysis using LC-ESI ion trap tandem mass spectrometry (2019 - Kathirvel Alagesan, Daniel Varon Silva, Peter H Seeberger, Daniel Kolarich) / Status : Reviewed
- Structural study of the N-linked oligosaccharides of hepatocyte growth factor by two-dimensional sugar mapping. (1993 - Hara H, Nakae Y, Sogabe T, Ihara I, Ueno S, Sakai H, Inoue H, Shimizu S, Nakamura T, Shimizu N) / Status : Reviewed
- Detailed structural analysis of asparagine-linked oligosaccharides of the nicotinic acetylcholine receptor from Torpedo californica. (1992 - Shoji H, Takahashi N, Nomoto H, Ishikawa M, Shimada I, Arata Y, Hayashi K) / Status : Reviewed
- Hepatocyte growth factor / Homo sapiens
-
Immunoglobulin alpha-2 heavy chain (secretory) - heavy chain 1 / Homo sapiens
- Undefined site
-
Immunoglobulin alpha-2 heavy chain (secretory) - heavy chain 2 / Homo sapiens
- Undefined site
-
Immunoglobulin alpha-2 heavy chain (secretory) - heavy chain 3 / Homo sapiens
- Undefined site
-
Acetylcholine receptor protein / Torpedo californica
- Undefined site
-
- N-Linked / Complex
(avg mass : 2589.3605)
- Toward robust N-glycomics of various tissue samples that may contain glycans with unknown or unexpected structures. (2021 - Suzuki N, Abe T, Hanzawa K, Natsuka S) / Status : Reviewed
- Structural analysis of N-linked sugar chains of human blood clotting factor IX. (2000 - Makino Y, Omichi K, Kuraya N, Ogawa H, Nishimura H, Iwanaga S, Hase S) / Status : Reviewed
-
Coagulation factor IX / Homo sapiens
- Undefined site
-
- N-Linked / Complex
(avg mass : 2589.3605)
- Ovary (UBERON_0000992) CHO (CVCL_0213)
- Hepatocyte growth factor / Homo sapiens
-
- N-Linked / Complex
(avg mass : 2589.3605)
- Dander
-
Uncharacterized protein from Dander / Equus caballus
- Undefined site
-
- N-Linked / Complex
(avg mass : 2589.3605)
- Diabetes Mellitus, Non-insulin dependent (DOID:9352)
- Hypercholesterolemia, Familial (DOID:13810)
-
Apolipoprotein B-100 / Homo sapiens
- Undefined site
-
- N-Linked / Complex
(avg mass : 2589.3605)
- Blood Serum (UBERON_0001977)
-
Alpha-2-hs-glycoprotein / Bos taurus
- Undefined site
-
- N-Linked / Complex
(avg mass : 2589.3605)
- COVID-19 (DOID:0080600)
- Virus-Receptor Interactions of Glycosylated SARS-CoV-2 Spike and Human ACE2 Receptor (2020 - Peng Zhao, Jeremy L. Praissman, Oliver C. Grant, Yongfei Cai, Tianshu Xiao, Katelyn E. Rosenbalm, Kazuhiro Aoki, Benjamin P. Kellman, Robert Bridger, Dan H. Barouch, Melinda A. Brindley, Nathan E. Lewis, Michael Tiemeyer, Bing Chen, Robert J. Woods, Lance Wells) / Status : Reviewed
- Detailed oligosaccharide structures of human integrin alpha 5 beta 1 analyzed by a three-dimensional mapping technique. (1996 - Nakagawa H, Zheng M, Hakomori S, Tsukamoto Y, Kawamura Y, Takahashi N) / Status : Reviewed
-
Angiotensin-converting enzyme 2 / Homo sapiens
- Undefined site
-
Integrin alpha-5/beta-1 / Homo sapiens
- Undefined site
-
- N-Linked / Complex
(avg mass : 2589.3605)
- Isolation and structure determination of the intact sialylated N-linked carbohydrate chains of recombinant human follitropin expressed in Chinese hamster ovary cells. (1990 - Hard K, Mekking A, Damm J, Kamerling J, de Boer W, Wijnands R, Vliegenthart J) / Status : Reviewed
- The asparagine-linked oligosaccharides on bovine fetuin. Structural analysis of N-glycanase-released oligosaccharides by 500-megahertz 1H NMR spectroscopy. (1988 - Green E, Adelt G, Baenziger J, Wilson S, Van Halbeek H) / Status : Reviewed
-
Follitropin, alpha and beta chains / Homo sapiens
- Undefined site
-
Alpha-2-hs-glycoprotein / Bos taurus
- Undefined site
-
- N-Linked / Complex
(avg mass : 2589.3605)
- Placenta (UBERON_0001987)
-
Integrin alpha-5/beta-1 / Homo sapiens
- Undefined site
-
- N-Linked / Complex
(avg mass : 2589.3605)
- Eveline (CVCL_A1LI)
- Envelope glycoprotein / Friend murine leukemia virus
-
- N-Linked / Complex
(avg mass : 2589.3605)
- Eveline (CVCL_A1LI)
- Envelope glycoprotein / Friend murine leukemia virus
-
- N-Linked / Complex
(avg mass : 2589.3605)
- Structures of sugar chains of hen egg yolk riboflavin-binding protein. (1993 - Tarutani M, Norioka N, Mega T, Hase S, Ikenaka T) / Status : Reviewed
- The Asn-linked carbohydrate chains of human Tamm-Horsfall glycoprotein of one male. Novel sulfated and novel N-acetylgalactosamine-containing N-linked carbohydrate chains. (1992 - Hard K, Van Zadelhoff G, Moonen P, Kamerling J, Vliegenthart F) / Status : Reviewed
- The asparagine-linked oligosaccharides on bovine fetuin. Structural analysis of N-glycanase-released oligosaccharides by 500-megahertz 1H NMR spectroscopy. (1988 - Green E, Adelt G, Baenziger J, Wilson S, Van Halbeek H) / Status : Reviewed
-
Uromodulin / Homo sapiens
- Undefined site
-
Alpha-2-hs-glycoprotein / Bos taurus
- Undefined site
-
Riboflavin-binding protein / Gallus gallus
- Undefined site
-
- N-Linked / Complex
(avg mass : 2589.3605)
- Placenta (UBERON_0001987)
-
Integrin alpha-5/beta-1 / Homo sapiens
- Undefined site
-
- N-Linked / Complex
(avg mass : 2589.3605)
- Blood Serum (UBERON_0001977)
-
Alpha-2-hs-glycoprotein / Bos taurus
- Undefined site
-
- N-Linked / Complex
(avg mass : 2589.3605)
- Identification of neutral and sialyl N-linked oligosaccharide structures from human serum glycoproteins using three kinds of high-performance liquid chromatography. (1995 - Nakagawa H, Kawamura Y, Kato K, Shimada I, Arata Y, Takahashi N) / Status : Reviewed
- Structures of sugar chains of hen egg yolk riboflavin-binding protein. (1993 - Tarutani M, Norioka N, Mega T, Hase S, Ikenaka T) / Status : Reviewed
- Structure determination of the glycans of human-serum alpha 1-antichymotrypsin using 1H-NMR spectroscopy and deglycosylation by N-glycanase. (1991 - Laine A, Hachulla E, Strecker G, Michalski J, Wieruszeski J) / Status : Reviewed
- The asparagine-linked oligosaccharides on bovine fetuin. Structural analysis of N-glycanase-released oligosaccharides by 500-megahertz 1H NMR spectroscopy. (1988 - Green E, Adelt G, Baenziger J, Wilson S, Van Halbeek H) / Status : Reviewed
-
Alpha-1-antichymotrypsin / Homo sapiens
- Undefined site
-
Uncharacterized protein from Blood Serum / Homo sapiens
- Undefined site
-
Alpha-2-hs-glycoprotein / Bos taurus
- Undefined site
-
Riboflavin-binding protein / Gallus gallus
- Undefined site
-
- N-Linked / Complex
(avg mass : 2589.3605)
- Eveline (CVCL_A1LI)
- Envelope glycoprotein / Friend murine leukemia virus
-
- N-Linked / Complex
(avg mass : 2589.3605)
-
Acetylcholinesterase / Bos taurus
- Undefined site
-
- N-Linked / Complex
(avg mass : 2589.3605)
- Blood Serum (UBERON_0001977)
- Haptoglobin / Homo sapiens
-
- N-Linked / Complex
(avg mass : 2589.3605)
- Blood Plasma (UBERON_0001969)
- Esophageal cancer (DOID:5041)
- Computational framework for identification of intact glycopeptides in complex samples (2014 - Mayampurath A, Yu CY, Song E, Balan J, Mechref Y, Tang H.) / Status : Reviewed
- Exploring site-specific N-glycosylation microheterogeneity of haptoglobin using glycopeptide CID tandem mass spectra and glycan database search (2013 - Chandler KB1, Pompach P, Goldman R, Edwards N.) / Status : Reviewed
- Haptoglobin / Homo sapiens
- Hemopexin / Homo sapiens
- Vitronectin / Homo sapiens
- Alpha-2-hs-glycoprotein / Bos taurus
-
- N-Linked / Complex
(avg mass : 2589.3605)
- Blood Plasma (UBERON_0001969)
- In-depth analysis of site-specific N-glycosylation in vitronectin from human plasma by tandem mass spectrometry with immunoprecipitation (2014 - Hwang H, Lee JY, Lee HK, Park GW, Jeong HK, Moon MH, Kim JY, Yoo JS.) / Status : Reviewed
- Site-specific N-glycosylation analysis of human factor XI: Identification of a noncanonical NXC glycosite (2014 - Faid V, Denguir N, Chapuis V, Bihoreau N, Chevreux G) / Status : Reviewed
- Coagulation factor XI / Homo sapiens
- Vitronectin / Homo sapiens
-
- N-Linked / Complex
(avg mass : 2589.3605)
- Blood Serum (UBERON_0001977)
-
Alpha-2-hs-glycoprotein / Bos taurus
- Undefined site
-
- N-Linked / Complex
(avg mass : 2589.3605)
- Ovary (UBERON_0000992) CHO (CVCL_0213)
- Erythropoietin / Homo sapiens
- SLNENITVPDTK (12aa)
-
- N-Linked / Complex
(avg mass : 2589.3605)
- Milk (UBERON_0001913)
- Alpha-1-acid glycoprotein 1 / Homo sapiens
- Alpha-1-antichymotrypsin / Homo sapiens
- Alpha-1-antitrypsin / Homo sapiens
- Alpha-2-HS-glycoprotein / Homo sapiens
- Beta-2-glycoprotein 1 / Homo sapiens
- Ceruloplasmin / Homo sapiens
- Clusterin / Homo sapiens
- Haptoglobin / Homo sapiens
- Polymeric immunoglobulin receptor / Homo sapiens
- Serotransferrin / Homo sapiens
- Vitronectin / Homo sapiens
- KWFYIASAFRNEEYNKS (17aa)
- KSVQEIQATFFYFTPNKT (18aa)
- KKKEDALNETRE (12aa)
- KKKEDALNETRESETKL (17aa)
- KNNATVHEQVGGPSLTSDLQAQSKG (25aa)
- RTLNQSSDELQLSMGNAMFVKE (22aa)
- RGLSFDVSLEVSQGPGLLNDTKV (23aa)
- KEHEGAIYPDNTTDFQRADDKV (22aa)
- KVCQDCPLLAPLNDTRV (17aa)
- RVYKPSAGNNSLYRD (15aa)
- KMVSHHNLTTGATLINEQWLLTTAKN (26aa)
- KNLFLNHSENATAKD (15aa)
- KVVLHPNYSQVDIGLIKL (18aa)
- KYLGNATAIFFLPDEGKL (18aa)
- KYTGNASALFILPDQDKM (18aa)
- RLANLTQGEDQYYLRV (16aa)
- KCGLVPVLAENYNKS (15aa)
- KWNNTGCQALPSQDEGPSKA (20aa)
- KELHHLQEQNVSNAFLDKG (19aa)
-
- N-Linked / Complex
(avg mass : 2589.3605)
- HEK293 (CVCL_0045)
- COVID-19 (DOID:0080600)
-
Angiotensin-converting enzyme 2 / Homo sapiens
- Undefined site
-
- N-Linked / Complex
(avg mass : 2589.3605)
- HEK293 (CVCL_0045)
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (HEK293) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- TQSLLIVNNATNVVIK (16aa)
- VYSSANNCTFE (11aa)
-
- N-Linked / Complex
(avg mass : 2589.3605)
- Colon (UBERON_0001155)
- LS174T (CVCL_1384)
- Colon adenocarcinoma (DOID:234)
-
Carcinoembryonic antigen-related cell adhesion molecule 5 / Homo sapiens
- Undefined site
-
- N-Linked / Complex
(avg mass : 2589.3605)
- Colon adenocarcinoma (DOID:234)
-
Carcinoembryonic antigen-related cell adhesion molecule 5 / Homo sapiens
- Undefined site
-
- N-Linked / Complex
(avg mass : 2589.3605)
- Colon (UBERON_0001155)
- LS174T (CVCL_1384)
- Colon adenocarcinoma (DOID:234)
-
Carcinoembryonic antigen-related cell adhesion molecule 5 / Homo sapiens
- Undefined site
-
- N-Linked / Complex
(avg mass : 2589.3605)
- Bone Marrow (UBERON_0002371)
-
- N-Linked / Complex
(avg mass : 2589.3605)
- Blood Serum (UBERON_0001977)
- Control/Healthy
- Familial hepatic adenoma (DOID:111366)
- Maturity-onset diabetes of the young type 3 (DOID:0111102)
-
Alpha-1-acid glycoprotein 1 / Homo sapiens
- Undefined site
-
Alpha-1-antitrypsin / Homo sapiens
- Undefined site
-
Serotransferrin / Homo sapiens
- Undefined site
-
- N-Linked / Complex
(avg mass : 2589.3605)
- Blood Plasma (UBERON_0001969)
-
Immunoglobulin heavy constant delta / Homo sapiens
- Undefined site
-
Immunoglobulin heavy constant delta - heavy chain 2 / Homo sapiens
- Undefined site
-
- N-Linked / Complex
(avg mass : 2589.3605)
- Blood Plasma (UBERON_0001969)
- Control/Healthy
-
Immunoglobulin heavy constant delta / Homo sapiens
- Undefined site
-
- N-Linked / Complex
(avg mass : 2589.3605)
- Blood Plasma (UBERON_0001969)
-
Immunoglobulin heavy constant epsilon - heavy chain 1 / Homo sapiens
- Undefined site
-
Immunoglobulin heavy constant epsilon - heavy chain 2 / Homo sapiens
- Undefined site
-
Immunoglobulin heavy constant mu / Homo sapiens
- Undefined site
-
- N-Linked / Complex
(avg mass : 2589.3605)
- Blood Plasma (UBERON_0001969)
-
Immunoglobulin heavy constant alpha 1 - heavy chain 1 / Homo sapiens
- Undefined site
-
Immunoglobulin heavy constant alpha 1 - heavy chain 2 / Homo sapiens
- Undefined site
-
Immunoglobulin heavy constant alpha 2 / Homo sapiens
- Undefined site
-
Immunoglobulin heavy constant alpha 2 - heavy chain 1 / Homo sapiens
- Undefined site
-
Immunoglobulin heavy constant epsilon - heavy chain 1 / Homo sapiens
- Undefined site
-
Immunoglobulin heavy constant epsilon - heavy chain 2 / Homo sapiens
- Undefined site
-
Immunoglobulin heavy constant mu / Homo sapiens
- Undefined site
-
- N-Linked / Complex
(avg mass : 2589.3605)
- Colon (UBERON_0001155)
-
- Hex:6 HexNAc:5 NeuAc:2 / N-Linked
(avg mass : 2589.3605)
- Blood Serum (UBERON_0001977)
- N-Linked / Complex / Gal(b1-4)GlcNAc(?1-?)[Gal(b1-4)GlcNAc(?1-?)]Man(a1-?)[Gal(b1-4)GlcNAc(?1-?)Man(a1-?)]Man(b1-4)GlcNAc(b1-4)GlcNAc+"+ 2 x NeuAc(a2-?)"
- N-Linked / Complex / Gal(b1-4)GlcNAc(?1-?)Man(a1-3)[Gal(b1-4)GlcNAc(?1-?)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc+"+ Gal(b1-4)GlcNAc(?1-?) + 2 x NeuAc(a2-?)"
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-4)]Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc+"+ 2 x NeuAc"
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-4)]Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc+"+ 2 x NeuAc(a2-3)"
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-4)]Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc+"+ 2 x NeuAc(a2-?)"
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-6)]Man(a1-6)[Gal(b1-4)GlcNAc(b1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)GlcNAc+"+ 2 x NeuAc(a2-3)"
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-?)]Man(a1-?)[Gal(b1-4)GlcNAc(b1-2)Man(a1-?)]Man(b1-4)GlcNAc(b1-4)GlcNAc+"+ 2 x NeuAc(a2-?)"
- N-Linked / Complex / Gal(b1-?)GlcNAc(b1-?)Man(a1-6)[Gal(b1-?)GlcNAc(b1-?)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)GlcNAc+"+ Gal(b1-?)GlcNAc(b1-?) + NeuAc(a2-3) + NeuAc(a2-6)"
- N-Linked / Complex / NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-4)]Man(a1-3)[NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-6)]Man(a1-6)[NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-2)[NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-4)]Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-2)[NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-6)]Man(a1-6)[Gal(b1-4)GlcNAc(b1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-6)]Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc+"+ NeuAc(a2-3)"
- N-Linked / Complex / NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-2)Man(a1-6)[Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-4)]Man(a1-3)]Man(b1-4)GlcNAc(b1-4)GlcNAc+"+ NeuAc(a2-?)"
- N-Linked / Complex / NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-4)[NeuAc(a2-6)Gal(b1-4)GlcNAc(b1-2)]Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-6)[Gal(b1-4)GlcNAc(b1-2)]Man(a1-6)[NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / NeuAc(a2-6)Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-4)]Man(a1-3)[NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / NeuAc(a2-6)Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-4)]Man(a1-3)[NeuAc(a2-6)Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / NeuAc(a2-6)Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-6)]Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc+"+ NeuAc(a2-3)"
- N-Linked / Complex / NeuAc(a2-?)Gal(b1-?)GlcNAc(?1-?)[NeuAc(a2-?)Gal(b1-?)GlcNAc(?1-?)]Man(a1-?)[Gal(b1-?)GlcNAc(?1-?)Man(a1-?)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / Structure 1479
- N-Linked / Complex / Structure 2391
- N-Linked / Complex / Structure 2691
- N-Linked / Complex / NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-4)[Gal(b1-4)GlcNAc(b1-2)]Man(a1-3)[NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / Structure 9319
- N-Linked / Complex / Structure 9462
- N-Linked / Complex / Structure 9821
- N-Linked / Complex / Structure 10038
- N-Linked / Complex / Structure 10438
- N-Linked / Complex / Structure 10456
- N-Linked / Complex / Structure 10501
- N-Linked / Complex / Structure 10612
- N-Linked / Complex / Structure 10693
- N-Linked / Complex / Structure 10898
- N-Linked / Complex / Structure 10908
- N-Linked / Complex / Structure 10926
- N-Linked / Complex / Structure 10932
- N-Linked / Complex / Structure 11148
- Alpha-2-hs-glycoprotein / Bos taurus
- RPTGEVYDIEIDTLETTCHVLDPTPLANCSVR (32aa)
- LCPDCPLLAPLNDSR (15aa)
- VVHAVEVALATFNAESNGSYLQLVEISR (28aa)
-
- Hex:6 HexNAc:5 NeuAc:2 / N-Linked
(avg mass : 2589.3605)
- Blood Serum (UBERON_0001977)
- Brain (UBERON_0000955)
- Mammary Gland (UBERON_0001911)
- Umbilical Vein (UBERON_0002066) Endothelial Cell of Umbilical Vein (CL_0002618)
- Urine (UBERON_0001088)
- FreeStyle 293-F (CVCL_D603)
- Jurkat (CVCL_0065)
- N-Linked / Complex / Gal(b1-4)GlcNAc(?1-?)[Gal(b1-4)GlcNAc(?1-?)]Man(a1-?)[Gal(b1-4)GlcNAc(?1-?)Man(a1-?)]Man(b1-4)GlcNAc(b1-4)GlcNAc+"+ 2 x NeuAc(a2-?)"
- N-Linked / Complex / Gal(b1-4)GlcNAc(?1-?)Man(a1-3)[Gal(b1-4)GlcNAc(?1-?)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc+"+ Gal(b1-4)GlcNAc(?1-?) + 2 x NeuAc(a2-?)"
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-4)]Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc+"+ 2 x NeuAc"
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-4)]Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc+"+ 2 x NeuAc(a2-3)"
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-4)]Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc+"+ 2 x NeuAc(a2-?)"
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-6)]Man(a1-6)[Gal(b1-4)GlcNAc(b1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)GlcNAc+"+ 2 x NeuAc(a2-3)"
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-?)]Man(a1-?)[Gal(b1-4)GlcNAc(b1-2)Man(a1-?)]Man(b1-4)GlcNAc(b1-4)GlcNAc+"+ 2 x NeuAc(a2-?)"
- N-Linked / Complex / Gal(b1-?)GlcNAc(b1-?)Man(a1-6)[Gal(b1-?)GlcNAc(b1-?)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)GlcNAc+"+ Gal(b1-?)GlcNAc(b1-?) + NeuAc(a2-3) + NeuAc(a2-6)"
- N-Linked / Complex / NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-4)]Man(a1-3)[NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-6)]Man(a1-6)[NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-2)[NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-4)]Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-2)[NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-6)]Man(a1-6)[Gal(b1-4)GlcNAc(b1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-6)]Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc+"+ NeuAc(a2-3)"
- N-Linked / Complex / NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-2)Man(a1-6)[Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-4)]Man(a1-3)]Man(b1-4)GlcNAc(b1-4)GlcNAc+"+ NeuAc(a2-?)"
- N-Linked / Complex / NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-4)[NeuAc(a2-6)Gal(b1-4)GlcNAc(b1-2)]Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-6)[Gal(b1-4)GlcNAc(b1-2)]Man(a1-6)[NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / NeuAc(a2-6)Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-4)]Man(a1-3)[NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / NeuAc(a2-6)Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-4)]Man(a1-3)[NeuAc(a2-6)Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / NeuAc(a2-6)Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-6)]Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc+"+ NeuAc(a2-3)"
- N-Linked / Complex / NeuAc(a2-?)Gal(b1-?)GlcNAc(?1-?)[NeuAc(a2-?)Gal(b1-?)GlcNAc(?1-?)]Man(a1-?)[Gal(b1-?)GlcNAc(?1-?)Man(a1-?)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / Structure 1479
- N-Linked / Complex / Structure 2391
- N-Linked / Complex / Structure 2691
- N-Linked / Complex / NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-4)[Gal(b1-4)GlcNAc(b1-2)]Man(a1-3)[NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / Structure 9319
- N-Linked / Complex / Structure 9462
- N-Linked / Complex / Structure 9821
- N-Linked / Complex / Structure 10038
- N-Linked / Complex / Structure 10438
- N-Linked / Complex / Structure 10456
- N-Linked / Complex / Structure 10501
- N-Linked / Complex / Structure 10612
- N-Linked / Complex / Structure 10693
- N-Linked / Complex / Structure 10898
- N-Linked / Complex / Structure 10908
- N-Linked / Complex / Structure 10926
- N-Linked / Complex / Structure 10932
- N-Linked / Complex / Structure 11148
- Cancer, breast (DOID:1612)
- COVID-19 (DOID:0080600)
- Prostate cancer (DOID:10283)
- T-cell childhood acute lymphocytic leukemia (DOID:0080145)
- Community evaluation of glycoproteomics informatics solutions reveals high-performance search strategies for serum glycopeptide analysis (2021 - Rebeca Kawahara, Anastasia Chernykh, Kathirvel Alagesan, Marshall Bern, Weiqian Cao, Robert J. Chalkley, Kai Cheng, Matthew S. Choo, Nathan Edwards, Radoslav Goldman, Marcus Hoffmann, Yingwei Hu, Yifan Huang, Jin Young Kim, Doron Kletter, Benoit Liquet, Mingqi Liu, Yehia Mechref, Bo Meng, Sriram Neelamegham, Terry Nguyen-Khuong, Jonas Nilsson, Adam Pap, Gun Wook Park, Benjamin L. Parker, Cassandra L. Pegg, Josef M. Penninger, Toan K. Phung, Markus Pioch, Erdmann Rapp, Enes Sakalli, Miloslav Sanda, Benjamin L. Schulz, Nichollas E. Scott, Georgy Sofronov, Johannes Stadlmann, Sergey Y. Vakhrushev, Christina M. Woo, Hung-Yi Wu, Pengyuan Yang, Wantao Ying, Hui Zhang, Yong Zhang, Jingfu Zhao, Joseph Zaia, Stuart M. Haslam, Giuseppe Palmisano, Jong Shin Yoo, Göran Larson, Kai-Hooi Khoo, Katalin F. Medzihradszky, Daniel Kolarich, Nicolle H. Packer, Morten Thaysen-Andersen) / Status : Reviewed
- Site-specific glycan analysis of the SARS-CoV-2 spike (2020 - Yasunori Watanabe, Joel D. Allen, Daniel Wrapp, Jason S. McLellan, Max Crispin) / Status : Unreviewed
- Capturing site-specific heterogeneity with large-scale N-glycoproteome analysis (2019 - Nicholas M. Riley, Alexander S. Hebert, Michael S. Westphall & Joshua J. Coon ) / Status : Unreviewed
- Glycoproteomic Analysis of MGL-Binding Proteins on Acute T-Cell Leukemia Cells. (2019 - Martina Pirro, Esmee Schoof, Sandra J. van Vliet, Yoann Rombouts, Alexandre Stella, Arnoud de Ru, Yassene Mohammed, Manfred Wuhrer, Peter A. van Veelen, Paul J. Hensbergen) / Status : Reviewed
- Site-Specific Profiling of Serum Glycoproteins Using N-Linked Glycan and Glycosite Analysis Revealing Atypical N-Glycosylation Sites on Albumin and α-1B-Glycoprotein (2018 - Shisheng Sun, Yingwei Hu, Li Jia, Shadi Toghi Eshghi, Yang Liu, Punit Shah, Hui Zhang) / Status : Unreviewed
- Reanalysis of global proteomic and phosphoproteomic data identified a large number of glycopeptides (2018 - Yingwei Hu, Punit Shah, David J. Clark, Minghui Ao, Hui Zhang) / Status : Unreviewed
- Large-scale intact glycopeptide identification by Mascot database search (2018 - Ravi Chand Bollineni, Christian Jeffrey Koehler, Randi Elin Gislefoss, Jan Haug Anonsen, Bernd Thiede) / Status : Unreviewed
- Distinct urinary glycoprotein signatures in prostate cancer patients (2018 - Rebeca Kawahara, Fabio Ortega, Livia Rosa-Fernandes, Vanessa Guimarães, Daniel Quina, Willian Nahas, Veit Schwämmle, Miguel Srougi, Katia R.M. Leite, Morten Thaysen-Andersen, Martin R. Larsen and Giuseppe Palmisano) / Status : Unreviewed
- Comparison of sialylated N-glycopeptide levels in serum of pancreatic cancer patients, acute pancreatitis patients, and healthy controls (2014 - Kontro H, Joenväärä S, Haglund C, Renkonen R) / Status : Reviewed
- Efficient and accurate glycopeptide identification pipeline for high-throughput site-specific N-glycosylation analysis (2014 - Liu M, Zhang Y, Chen Y, Yan G, Shen C, Cao J, Zhou X, Liu X, Zhang L, Shen H, Lu H, He F, Yang P) / Status : Reviewed
- Selective glycopeptide profiling by acetone enrichment and LC/MS (2014 - Takakura D, Harazono A, Hashii N, Kawasaki N) / Status : Reviewed
- Glycoproteomic analysis of the secretome of human endothelial cells (2013 - Yin X, Bern M, Xing Q, Ho J, Viner R, Mayr M.) / Status : Reviewed
- Simultaneous glycosylation analysis of human serum glycoproteins by high-performance liquid chromatography/tandem mass spectrometry (2008 - Harazono A, Kawasaki N, Itoh S, Hashii N, Matsuishi-Nakajima Y, Kawanishi T, Yamaguchi T) / Status : Reviewed
- ADAM DEC1 / Homo sapiens
- ADAMTS-like protein 2 / Homo sapiens
- Adenosine deaminase 2 / Homo sapiens
- Adhesion G protein-coupled receptor F5 / Homo sapiens
- Adhesion G protein-coupled receptor L4 / Homo sapiens
- Adhesion G-protein coupled receptor D1 / Homo sapiens
- Alpha-1-acid glycoprotein 1 / Homo sapiens
- Alpha-1-acid glycoprotein 2 / Homo sapiens
- Alpha-1-antichymotrypsin / Homo sapiens
- Alpha-1-antitrypsin / Homo sapiens
- Alpha-1b-glycoprotein / Homo sapiens
- Alpha-2-HS-glycoprotein / Homo sapiens
- Alpha-2-macroglobulin / Homo sapiens
- Alpha-n-acetylglucosaminidase / Homo sapiens
- Angiopoietin-1 receptor / Homo sapiens
- Angiopoietin-related protein 4 / Homo sapiens
- Angiotensin-converting enzyme / Homo sapiens
- Angiotensinogen / Homo sapiens
- Apolipoprotein (a) / Homo sapiens
- Apolipoprotein B-100 / Homo sapiens
- Apolipoprotein D / Homo sapiens
- Apolipoprotein F / Homo sapiens
- Asialoglycoprotein receptor 2 / Homo sapiens
- Attractin / Homo sapiens
- Basement membrane-specific heparan sulfate proteoglycan core protein / Homo sapiens
- Beta-2-glycoprotein 1 / Homo sapiens
- Beta-Ala-His dipeptidase / Homo sapiens
- Biotinidase / Homo sapiens
- Bone marrow stromal antigen 2 / Homo sapiens
- C4b-binding protein alpha chain / Homo sapiens
- C4b-binding protein beta chain / Homo sapiens
- Cadherin-13 / Homo sapiens
- Carboxypeptidase b2 / Homo sapiens
- Carboxypeptidase N subunit 2 / Homo sapiens
- Catalase / Homo sapiens
- Cathepsin D / Homo sapiens
- Cathepsin L1 / Homo sapiens
- CD109 antigen / Homo sapiens
- CD166 antigen / Homo sapiens
- CD276 antigen / Homo sapiens
- CD44 antigen / Homo sapiens
- CD48 antigen / Homo sapiens
- Ceruloplasmin / Homo sapiens
- Cholesteryl ester transfer protein / Homo sapiens
- Clusterin / Homo sapiens
- Coagulation factor VIII / Homo sapiens
- Coagulation factor XI / Homo sapiens
- Coagulation factor XIII B chain / Homo sapiens
- Collagen alpha-3(VI) chain / Homo sapiens
- Complement factor h / Homo sapiens
- Complement factor H-related protein 1 / Homo sapiens
- Complement factor H-related protein 3 / Homo sapiens
- Complement factor H-related protein 4 / Homo sapiens
- Complement factor i / Homo sapiens
- Contactin-3 / Homo sapiens
- Contactin-4 / Homo sapiens
- Corticosteroid-binding globulin / Homo sapiens
- Decorin / Homo sapiens
- Desmoglein-2 / Homo sapiens
- Ecto-ADP-ribosyltransferase 4 / Homo sapiens
- Endoplasmic reticulum aminopeptidase 2 / Homo sapiens
- Endothelial cell-selective adhesion molecule / Homo sapiens
- Endothelin-converting enzyme 1 / Homo sapiens
- Epidermal growth factor receptor / Homo sapiens
- Epididymis-specific alpha-mannosidase / Homo sapiens
- Extracellular matrix protein 1 / Homo sapiens
- Extracellular sulfatase Sulf-2 / Homo sapiens
- Fibrillin-1 / Homo sapiens
- Fibroleukin / Homo sapiens
- Frizzled-6 / Homo sapiens
- G-protein coupled receptor 126 / Homo sapiens
- Galectin-3-binding protein / Homo sapiens
- Gamma-glutamyltranspeptidase 1 / Homo sapiens
- Glutaminase kidney isoform, mitochondrial / Homo sapiens
- Glycocalicin / Homo sapiens
- Haptoglobin / Homo sapiens
- Hemopexin / Homo sapiens
- Heparin cofactor 2 / Homo sapiens
- Hepatocyte growth factor activator / Homo sapiens
- Hepatocyte growth factor receptor / Homo sapiens
- HLA class II histocompatibility antigen, DP alpha 1 chain / Homo sapiens
- Homeobox protein Hox-B3 / Homo sapiens
- IgGFc-binding protein / Homo sapiens
- Immunoglobulin heavy constant alpha 1 / Homo sapiens
- Immunoglobulin heavy constant alpha 2 / Homo sapiens
- Immunoglobulin heavy constant gamma 2 / Homo sapiens
- Immunoglobulin heavy constant mu / Homo sapiens
- Integrin alpha-5 / Homo sapiens
- Inter-alpha-trypsin inhibitor heavy chain h1 / Homo sapiens
- Inter-alpha-trypsin inhibitor heavy chain h2 / Homo sapiens
- Inter-alpha-trypsin inhibitor heavy chain h4 / Homo sapiens
- Intercellular adhesion molecule 2 / Homo sapiens
- Interleukin-1 receptor accessory protein / Homo sapiens
- Interleukin-1 receptor-like 1 / Homo sapiens
- Interleukin-6 receptor subunit beta / Homo sapiens
- Junction plakoglobin / Homo sapiens
- Kallistatin / Homo sapiens
- Keratin, type I cytoskeletal 9 / Homo sapiens
- Kininogen-1 / Homo sapiens
- Lactotransferrin / Homo sapiens
- Laminin subunit alpha-2 / Homo sapiens
- Laminin subunit alpha-4 / Homo sapiens
- Laminin subunit gamma-1 / Homo sapiens
- Latent transforming growth factor beta binding protein 1 / Homo sapiens
- Leptin receptor / Homo sapiens
- Leucine-rich repeat-containing protein 15 / Homo sapiens
- Leucyl-cystinyl aminopeptidase / Homo sapiens
- Lipopolysaccharide-binding protein / Homo sapiens
- Lumican / Homo sapiens
- Lysosome-associated membrane glycoprotein 1 / Homo sapiens
- Lysosome-associated membrane glycoprotein 2 / Homo sapiens
- Macrophage colony-stimulating factor 1 receptor / Homo sapiens
- Maltase-glucoamylase, intestinal / Homo sapiens
- Mannan-binding lectin serine protease 1 / Homo sapiens
- Mesothelin / Homo sapiens
- Mimecan / Homo sapiens
- Multimerin-1 / Homo sapiens
- Multimerin-2 / Homo sapiens
- Multiple epidermal growth factor-like domains protein 8 / Homo sapiens
- Myeloperoxidase / Homo sapiens
- Neogenin / Homo sapiens
- Neuron navigator 2 / Homo sapiens
- Noelin / Homo sapiens
- Oncoprotein-induced transcript 3 protein / Homo sapiens
- Oncostatin-M-specific receptor subunit beta / Homo sapiens
- Peroxidasin homolog / Homo sapiens
- Phosphatidylinositol-glycan-specific phospholipase D / Homo sapiens
- Plasma protease c1 inhibitor / Homo sapiens
- Plasma serine protease inhibitor / Homo sapiens
- Plasminogen / Homo sapiens
- Platelet endothelial cell adhesion molecule / Homo sapiens
- Platelet glycoprotein V / Homo sapiens
- Platelet-derived growth factor subunit b / Homo sapiens
- Plexin-B1 / Homo sapiens
- Plexin-B2 / Homo sapiens
- Prolactin-inducible protein / Homo sapiens
- Prolargin / Homo sapiens
- Prolow-density lipoprotein receptor-related protein 1 / Homo sapiens
- Prostaglandin-h2 d-isomerase / Homo sapiens
- Protein heg homolog 1 / Homo sapiens
- Prothrombin / Homo sapiens
- Receptor-type tyrosine-protein phosphatase C / Homo sapiens
- Receptor-type tyrosine-protein phosphatase gamma / Homo sapiens
- Receptor-type tyrosine-protein phosphatase kappa / Homo sapiens
- Receptor-type tyrosine-protein phosphatase mu / Homo sapiens
- Scavenger receptor cysteine-rich type 1 protein M130 / Homo sapiens
- Secretogranin-3 / Homo sapiens
Source
Suggested structure
Disease
Reference
Reported glycosite
- Hex:6 HexNAc:5 NeuAc:2 / N-Linked
(avg mass : 2589.3605)
Source
Suggested structure
Reported glycosite
Mass spectrometry observed peptide
- Hex:6 HexNAc:5 NeuAc:2 / N-Linked
(avg mass : 2589.3605)
Source
Reported glycosite
- N-Linked / Complex
(avg mass : 2589.3605)
Source
Reported glycosite
- N-Linked / Complex
(avg mass : 2589.3605)
Source
Reported glycosite
- N-Linked / Complex
(avg mass : 2589.3605)
Source
Disease
Reported glycosite
- N-Linked / Complex
(avg mass : 2589.3605)
Source
Reported glycosite
- N-Linked / Complex
(avg mass : 2589.3605)
Source
Disease
Reported glycosite
- N-Linked / Complex
(avg mass : 2589.3605)
Source
Reported glycosite
- N-Linked / Complex
(avg mass : 2589.3605)
Source
Disease
Reported glycosite
- N-Linked / Complex
(avg mass : 2589.3605)
Disease
Reported glycosite
- N-Linked / Complex
(avg mass : 2589.3605)
Source
Disease
Reported glycosite
- N-Linked / Complex
(avg mass : 2589.3605)
Source
Disease
Reported glycosite
Mass spectrometry observed peptide
- N-Linked / Complex
(avg mass : 2589.3605)
Source
Disease
Reported glycosite
- N-Linked / Complex
(avg mass : 2589.3605)
Source
Reported glycosite
Mass spectrometry observed peptide
- N-Linked / Complex
(avg mass : 2589.3605)
Source
Reported glycosite
Mass spectrometry observed peptide
- N-Linked / Complex
(avg mass : 2589.3605)
Source
Reported glycosite
- N-Linked / Complex
(avg mass : 2589.3605)
Source
Reference
Reported glycosite
- N-Linked / Complex
(avg mass : 2589.3605)
Source
Disease
Reference
Reported glycosite
- N-Linked / Complex
(avg mass : 2589.3605)
Source
Reported glycosite
- N-Linked / Complex
(avg mass : 2589.3605)
Reported glycosite
- N-Linked / Complex
(avg mass : 2589.3605)
Source
Reported glycosite
- N-Linked / Complex
(avg mass : 2589.3605)
Reference
Reported glycosite
- N-Linked / Complex
(avg mass : 2589.3605)
Source
Reported glycosite
- N-Linked / Complex
(avg mass : 2589.3605)
Source
Reported glycosite
- N-Linked / Complex
(avg mass : 2589.3605)
Reference
Reported glycosite
- N-Linked / Complex
(avg mass : 2589.3605)
Source
Reported glycosite
- N-Linked / Complex
(avg mass : 2589.3605)
Source
Reported glycosite
- N-Linked / Complex
(avg mass : 2589.3605)
Source
Reported glycosite
- N-Linked / Complex
(avg mass : 2589.3605)
Reference
Reported glycosite
- N-Linked / Complex
(avg mass : 2589.3605)
Disease
Reference
Reported glycosite
- N-Linked / Complex
(avg mass : 2589.3605)
Source
Reported glycosite
- N-Linked / Complex
(avg mass : 2589.3605)
Disease
Reported glycosite
- N-Linked / Complex
(avg mass : 2589.3605)
Source
Reported glycosite
- N-Linked / Complex
(avg mass : 2589.3605)
Source
Reported glycosite
- N-Linked / Complex
(avg mass : 2589.3605)
Reference
Reported glycosite
- N-Linked / Complex
(avg mass : 2589.3605)
Source
Disease
Reference
Reported glycosite
- N-Linked / Complex
(avg mass : 2589.3605)
Source
Reported glycosite
- N-Linked / Complex
(avg mass : 2589.3605)
Source
Reported glycosite
- N-Linked / Complex
(avg mass : 2589.3605)
Source
Reported glycosite
- N-Linked / Complex
(avg mass : 2589.3605)